abstracts presented at meetings july 1, 2001 – june 30, … · web viewadam hj, schurek kn, hoban...

ABSTRACTS PRESENTED AT MEETINGS JULY 1, 2005 – JUNE 30, 2006

Adam HJ, Schurek KN, Hoban C, Greisman J, Nichol K, Hoban DJ and Zhanel GG. Molecular characterization of fluoroquinolone-resistant Streptococcus pneumoniae isolates in Canada from 1997-2004. America Society for Microbiology (ASM), New Orleans, Louisiana, 2005.

Al Hamoudi, W., Fonseca, K., Osiowy, C., and Burak, K. (2006) Treatment of Lamivudine Resistant HBV Following Liver Transplantation. [Presented at the 2006 2nd Annual Canadian Association for the Study of Liver Winter Meeting, Toronto, ON].

Al-Azem A, Elliott L, Kabani A, Hershfield E. Social Network Analysis in Tuberculosis Control. International Centre for Infectious Diseases Scientific Retreat, Winnipeg, MB. October 2005.

Alfa MJ, Harding GK, DeGagne P, Sheard B. The Rapid Group B Streptococcus PCR Test Provides a Method for Reliable Detection of Group B Streptococcus Carriage in Women in Labour. Presented at the Association of Medical Microbiology and Infectious Diseases Canada (AMMI Canada)-Canadian Association of Clinical Microbiology and Infectious Diseases (CACMID) 2006 Annual Conference. Victoria, British Columbia. March 15-19, 2006.

Alfa MJ, Harding GK, DeGagne P. Evaluation of the Antibiotic Susceptibility Pattern for Toxigenic Clostridium difficile Isolates from Manitoba over the Past 14 Years. Presented at the Association of Medical Microbiology and Infectious Diseases Canada (AMMI Canada)-Canadian Association of Clinical Microbiology and Infectious Diseases (CACMID) 2006 Annual Conference. Victoria, British Columbia. March 15-19, 2006.

Alfa MJ, Harding GK, Pang P, Wold A. Comparison of Triage and TechLab Tests for Detection of Clostridium difficile- Associated diarrhea (CDAD) in Stool Samples. Presented at the Association of Medical Microbiology and Infectious Diseases Canada (AMMI Canada)-Canadian Association of Clinical Microbiology and Infectious Diseases (CACMID) 2006 Annual Conference. Victoria, British Columbia. March 15-19, 2006.

Ali J, Chun E, Liao N, Liu J, Palmquist D, Wynhoven B, Huang P, Kirkpatrick R, Siddiqui A, Holt R, Marra M, Jones S. Finishing in the Future. Santa Fe, NM. May 2006. A high throughput bovine full length cDNA sequencing pipeline.

Ali J, Wynhoven B, Palmquist D, Chun HJE, Liu J, Kirkpatrick R, Stott J, Barber S, Yang G, Babakaiff R, Beland J, Chand S, Del Rio L, Dreolini L, Featherstone R, Gibson S, Matsuo C, Mayo M, Roger J, Tsai M, Wong D, Moore SS, Guan LL, Lobo S, Meng Y, Taniguchi M, Wang Z, Schreiber K, Prange C, Shapiro N, Shenmen C, Wagner L, Alexander L, MacNeil M, Brownstein MJ, Siddiqui A, Holt R, Jones S, Marra M. Plant and Animal Genome XIV Conference. San Diego, CA. January 2006. An Efficient Strategy for Full Length cDNA Sequence Finishing in Bos Taurus.

Ali J, Wynhoven B, Palmquist D, Elizabeth Chun H-J, Liu J, Kirkpatrick R, Stott J, Barber S, Yang G, Babakaiff R, Beland J, Chand S, Del Rio L, Dreolini L, Featherstone R, Gibson S, Matsuo C, Mayo M, Roger J, Tsai M, Wong D, Moore SS, Guan LL, Lobo S, Meng Y, Taniguchi M, Wang Z, Schreiber K, Prange C, Shapiro N, Shenmen C, Wagner L, Alexander L, MacNeil M, Brownstein MJ, Siddiqui A, Holt R, Jones S, Marra M. 2006 Genomics Forum: Student Biotechnology Network Research Exchange. Vancouver, BC. April 2006. An Efficient Strategy for Full Length cDNA Sequence Finishing in Bos Taurus.

Andonov Anton, Shaun Tyler, Mike Drebot, Elsie Grudeski, Maya Traykova-Andonova, Jody Berry, Runtao He and Todd Cutts. Molecular evolution of SARS coronavirus (SARS-CoV) in vitro: putative open reading frames (ORFs) 9, 10, 11 are not essential for virus replication. Public Health Agency of Canada, National Microbiology Laboratory; CACMID, Victoria 2006.

Andrysiak AK, Tracz DM, Olson AB, the Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) Collaborative and Gilmour MW. Genetic Relatedness of Clinical and Agricultural Multi-Drug Resistant Salmonella enterica serovar Heidelberg. PHAC Research Forum, Public Health Agency of Canada, March 20-21st, Winnipeg, Manitoba, 2006.

Aoki, FY, Tyring S, Diaz-Mitoma F et al. One-day, patient-initiated famciclovir therapy for recurrent genital herpes: randomized, double-blind, placebo-controlled trial. Abstract TP-005. International Society for Sexually Transmitted Diseases Research, July 10-13, 2005, Amsterdam, Netherlands.

Aramini JJ, Edge V, McDonald L, Mukhi S, Kabani A, Hoffman E, Honke D, Parker S. June 2005. Real-time biosurveillance and response readiness using an interconnected, electronic information infrastructure: A region-wide technology demonstration project with the Winnipeg Regional Health Authority. Poster. Proceedings of the 2005 CRTI Summer Symposium, 20-22 June 2005, Gatineau Quebec, pp99-100. http://www.crti.drdc-rddc.gc.ca/en/publications/symposium_proceedings/CRTI_symposium_ proceedings_2005_e.pdf.

Arsenio Janilyn, Yvon Deschambault, Jingxin Cao. Comparative Analysis of Interferon Sensitivity of Vaccinia virus Copenhagen strain and its E3L deletion mutant with Type I, Type II, and Type III Inteferons. American Society for Virology 25th Annual Meeting. University of Wisconsin-Madison, Madison, WI. July 15-19, 2006.

Arsenio Janilyn, Yvon Deschambault, Jingxin Cao. Examination of the potential of HCV proteins core, E2, NS3, NS3NS4a, and NS5a in Suppressing Type I and Type II Interferons utilizing Vaccinia Virus E3L deletion mutant based system 13th International Meeting on Hepatits C Virus & Related Viruses. Cairns Convention Centre, Queensland, Australia. August 27-31, 2006.

Arsenio Janilyn, Yvon Deschambault, Lindsay Alston, Jingxin Cao. Use of a Vaccinia Virus E3L Deletion Mutant Based System to Study Viral Proteins Suppressing Interferon Activities. PHAC Research Forum, March 20-21, 2006.

Backhouse, P.G., M.W. Gilmour, M.R. Graham, and L.-K. Ng. A normalization and analysis strategy to define biological variation in comparative genomic microarray hybridizations. Poster presented at CACMID, April 14-17, 2005, Ottawa, Canada. Abstract published in The Canadian Journal of Infectious Diseases & Medical Microbiolgy. 16(2):138.

Backhouse, P.G., M.W. Gilmour, M.R. Graham, and L.-K. Ng. Defining Biological Variation in Comparative Genomic Microarray Hybridization Studies of Neisseria gonorrhoeae. Poster presented at ISSTDR Biennial meeting June, mei2005. Amsterdam, Netherland. Abstract published on page 268 of meeting program.

Bainbridge MN, Warren RL, Hirst M, Romanuik T, Zeng T, Go A, Delany A, Griffith M, Hickenbotham M, Magrini V, Mardis ER, Sadar MD, Siddiqui AS, Marra MA, Jones SJM. 2006 Genomics Forum: Student Biotechnology Network Research Exchange. Vancouver, BC. April 2006. Analysis of the prostate cancer cell line LNCaP transcriptome using a sequencing-by-synthesis approach.

Baross A, Delaney AD, Ally A, Arbour L, Asano J, Bailey D, Birch P, Brown-John M, Cao M, Chan S, Charest DL, Eydoux P, Farnoud N, Fernandes N, Flibotte S, Go A, Gibson WT, Holt RA, Jones S, Kennedy G, Krzywinski M, Langlois S, Li HI, McGillivray BC, Nayar T, Schein J, Schnerch A, Siddiqui A, Yong S-L, Friedman JM, Marra MA. The Biology of Genomes. Cold Spring Harbor Laboratory, NY. May 2006. Genome copy number analysis of idiopathic mental retardation using high-density oligonucleotide microarrays.

Baross A, Delaney AD, Asano J, Bailey D, Birch P, Brown-John M, Cao M, Chan S, Charest DL, Eydoux P, Farnoud N, Fernandes N, Flibotte S, Go A, Holt RA, Jones S, Kennedy G, Krzywinski M, Langlois S, Li HI, Nayar T, Schein J, Siddiqui A, Friedman JM, Marra MA. 2006 AGBT Meeting. Marco Island, FL. February 2006. Genome copy number analysis of idiopathic mental retardation using high-density ogligonucleotide microarrays.

Barton C, Ng L-K, Clark C. Temperate Phages Affect Pulsed Field Gel Electrophoresis Typing of Campylobacter jejuni. Annual Federal Food Safety and Nutrition Research Meeting, Ottawa, November, 2005.

Barton C, Ng L-K, Clark C. Temperate Phages Affect Pulsed Field Gel Electrophoresis Typing of Campylobacter jejuni. Western Canadian Campylobacter Symposium, October, 2005.

http://www.crti.drdc-rddc.gc.ca/en/publications/symposium_proceedings/CRTI_symposium_%20proceedings_2005_e.pdf


Bastien N, Anderson K, Hart L, Miely D, Brandt K, Van Caeseele P, Hatchette T, and Li Y. Prevalence of human coronavirus NL-63 in Canada. The 1st Annual Public Health Agency of Canada (PHAC) Research Forum. Winnipeg, MB, Canada (March 20-21, 2006).

Bastien N, Brandt K, Dust K, Ward D, and Li Y. Identification of human bocavirus (HBoV) in Canada. The 1st Annual Public Health Agency of Canada (PHAC) Research Forum. Winnipeg, MB, Canada (March 20-21, 2006).

Becker M, Washington R, Stephen J, Maclean I, Alary M, Blanchard J, Moses S. Etiology of genital ulcers in Karnataka, India [Abstract TP-132]. XV Biennial Congress of the International Society for STD Research (ISSTDR), Amsterdam, The Netherlands, July 10-13, 2005.

Beeston A, Barton C, Liu C, Wang G, Ng L-K, Cuff W, Graham M, Clark C. Development of a DNA microarray for detecting virulence genes of enteric pathogens. Annual Federal Food Safety and Nutrition Research Meeting, Ottawa, November, 2005.

Beeston A, Bryden L, Wang G, Barton C, Gilmour M, Ng L-K, Clark C. Relationships between the sequence of the major outer membrane protein of Campylobacter jejuni with clinical outcome and serotype. Annual Federal Food Safety and Nutrition Research Meeting, Ottawa, November, 2005.

Beeston A, Bryden L, Wang G, Barton C, Gilmour M, Ng L-K, Clark C. Relationships between the sequence of the major outer membrane protein of Campylobacter jejuni with clinical outcome and serotype. Western Canadian Campylobacter Symposium, October, 2005.

Beniac, D.R., A.Andonov, and T.F.Booth. The SARS coronavirus: Purification and 3D structure of the spike by electron microscopy. 2005 International Centre for Infectious Diseases Research and Innovation Retreat, 28 - 29 October 2005 in Winnipeg, Manitoba. 2005.

Bernard K et al. Investigation of a unique case with potential for bioterrorism or biocrime. Public Health Agency of Canada Research Forum March 20, 2006 (as a poster).

Bernard K, A. Levesque, C. Babcock, K. Seifert. Creating a National Culture Collection for Canada. 74th CACMID comeeting with AMMI Victoria, BC. March 17 2006, abstract cited in Can. J Inf. Dis. Med Microbiol. 17:48. (oral, O-3)

Bernard K, A. Levesque, C. Babcock, K. Seifert. Creating a National Culture Collection for Canada. Public Health Agency of Canada Research Forum March 20, 2006 (as a poster).

Bernard K, D. Gordon, C. Munro. Assignment to genus and species for taxa originally identified as coryneform CDC groups A-4, A-5 or resembling Microbacterium using 16SrRNA gene sequencing. 106th Annual General Meeting American Society for Microbiology. Orlando, Fl. May 23, 2006 poster C-189.

Berry, JD, Elias, MD, Yuan, X, Garbutt, M., Simpson, L, Cassan, RR, Corbett, CR, Tsang, R. 2006. Comparative development of monoclonal antibody to Clostridial neurotoxins using a high-throughput homogeneous assay and conventional ELISA. IBC Antibody Development & Production; Successful Upstream and Downstream Processing Approaches. March 1-3, Carlsbad, CA.

Berry, JD.; Corbett, C., et al., 2006. CRTI 03-0021TD: Assay Development and Production Team for Developing, Validating, Producing, and Distributing Assays for the Identification of Bioterrorism Agents: Development of New Antibodies and Reagents to botulinum neurotoxins, CRTI Summer Symposium 2006, June 3-6, Gatineau Quebec.

Berry, JD.; Gubbins M., et al., 2006. CRTI 03-0021TD: Assay Development and Production Team for Developing, Validating, Producing, and Distributing Assays for the Identification of Bioterrorism Agents: Development of New Antibodies and Reagents to F. tularensis and Y. pestis, CRTI Summer Symposium 2006, June 3-6, Gatineau Quebec.

Bettinger JA, Halperin SA, DeSerres G, Scheifele DW, Tam T, IMPACT (J Embree, site coordinator). Appropriately vaccinated children among hospitalized pertussis cases. Vaccine Research Conference, Baltimore, MD, May 8, 2006.

Bettinger JA, Scheifele DW, LeSaux N, Halperin S, IMPACT (J Embree, site coordinator). Age distribution and serogroups of meningococcal invasive infections across Canada, 2002-2004. 83rd Annual Conference of the Canadian Paediatric Society, St John’s Newfoundland & Labrador, June 14, 2006.

Bialek J, Hoang-Vu C, Klonisch T (2006) A role for relaxin and INSL3 in tumor cell invasiveness. 50. Tagung der Deutschen Gesellschaft für Endokrinologie (DGE), Essen, Germany.

Boese, D, Tsang, R, Corbett, C, Yuan, X, Cassan, R, Gubbins, M, Plummer, F, JD Berry. 2006. Development of a chimeric neutralizing monoclonal antibody specific for Bacillus anthracis protective antigen. 1st Annual Public Health Agency of Canada (PHAC) Research Forum, Mar. 20-21, Winnipeg.

Booth T, Kournikakis B, Bastien N, Ho J, Kobasa D, Stadnyk L, Li Y, Spence M, Paton S, Henry B, Mederski B, White D, Low D, McGeer A, Simor A, Vearncombe M, Downey J, Jamieson F.B, Tang P, and Plummer F. Investigation of airborne SARS-coronavirus and environmental contamination in SARS outbreak units. XIII International Congress of Virology, San Francisco, CA, USA, p231:250-V (July 23-28, 2005).

Bouchillon S, Hoban D, Johnson B, Jordan A, Scangarella N, Shawar R, Johnson J. Retapamulin (sb-275833), a novel pleuromutilin – a multi-center global surveillance of activity against 3,797 beta and alpha hemolytic streptococci isolated from skin and skin structure infections (SSSIs). 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, December 2005.

Bouchillon S, Stevens T, Johnson J, Hoban D, Johnson B, Dowzicky M. Methicillin-resistant Staphylococcus aureus (810) collected from a recent global propulation: Tigeclycine in vitro evaluation. 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, December 2005.

Bouchillon S, Stevens T, Johnson J, Hoban D, Johnson B, Dowzicky M. Tigecycline in vitro evaluation of 1,145 methicillin-resistant Staphylococcus aureus. 16th European Congress of Clinical Microbiology and Infectious Diseases (ECCMD), Nice, France, April 2006.

Bouchillon S, Stevens T, Johnson J, Hoban D, Johnson B, Dowzicky M. The in vitro activity of tigecycline and 10 comparators in a global population – T.E.S.T. Program 2006. 16th European Congress of Clinical Microbiology and Infectious Diseases (ECCMD), Nice, France, April 2006.

Bouchillon S, Stevens T, Johnson J, Hoban D, Johnson B, Dowzicky M. Antibiotic cross resistance for Staphylococcus aureus and Enterococcus spp among tigecycline and 10 comparator antimicrobial agents – T.E.S.T. Program in Europe 2006. 16th European Congress of Clinical Microbiology and Infectious Diseases (ECCMD), Nice, France, April 2006.

Boutilier J. and M.S.Carpenter. Alterations to host cell protein phosphorylation induced by HCV subgenomic replicon. 12th International meeting on hepatitis C virus and related viruses, Montreal, PQ, Oct 2-6, 2005. Poster P-52.

Boyd, D. A., R. Hizon, M. Miller, M. R. Mulvey. Enterococcus gallinarum N04-0414 Harbors VanD-Type Vancomycin Resistance and is Missing the ddl2 Gene. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Washington, DC, December 16 – 19, 2005.

Brabant D, Michael P, Tonnos M, Tessier M, Kung S, Ramana CV, Parrillo JE, Kumar Anand and Kumar Aseem. Identification and characterization of mediators of sepsis. ACFUS, Montreal, Canada. March 2006.

Brabant D, Michael P, Tonnos M, Tessier M, Kung S, Ramana CV, Parrillo JE, Kumar Anand and Kumar Aseem. Sepsis mediated cellular dysfunction is mediated by DFF 40-induced apoptosis. NOSM Lakehead Research Conference. June 2006.

Burton E, Gawande PV, Yakandawala N, LoVetri K, Zhanel GG, Romeo T, Friesen AD and Madhyastha S. Antibiofilm activity of GlmU enzyme inhibitors against catheter-associated uropathogens. International Center for Infectious Diseases Conference, Winnipeg, Manitoba, November 5, 2005.

Card CM and Fowke KR. Role of CD4+ CD25+ regulatory T cells in limiting antigen-specific responses in HIV-infected patients. 2005 International Centere for Infectious Diseases Research and Innovation Retreat. Oct 28-29, 2005. Winnipeg, MB.

Card CM, Koesters SA, Fowke KR and Plummer FA. Characterization of CD4+ CD25+ regulatory T cells in a group of HIV-resistant commercial sex workers. Public Health Agency of Canada Research Forum. March 20-21, 2006. Winnipeg, MB.

Card CM, Koesters SA, Fowke KR. Role of CD4+ CD25+ regulatory T cells in susceptibility to HIV infection. 15th Annual Canadian Conference on HIV/AIDS Research (CAHR). May 25-28, 2006. Quebec City, Quebec

Chen R, Harris R and Dawood M (2005).Development of murine monoclonal antibodies (MAbs)Capable of neutralizing vaccinia virus (VV). University of Manitoba Symposium on Infection, Immunity and Health. Winnipeg, Manitoba, Canada.

Chen R, Van Caeseele P, Dawood M. Production of murine monoclonal antibodies (MAbs) with different neutralizing abilities for intracellular mature (IMV) and extracellular enveloped (EEV) vaccinia virus particles. Presented at International Centre for Infectious Disease Conference, Winnipeg, MB, 2005.

Choudhri Y., S.Cule, M. Hennink, P. Millson, C Morissette, M. W. Fyfe, S. Snelling, J. L. Wylie, A. Singh, C. P. Archibald and the I-Track Study Team. I-Track: Observed Increase in Prevalence of HIV among Injecting Drug Users in Two Rounds of I-Track Survey. 2005. Int. Harm Reduction Conf. Vancouver, BC.

Christianson, S., and M. R. Mulvey. A Comparative Genomic Hybridization Study of Methicillin Resistant Staphylococcus aureus in Canada. The 1st Annual Public Health Agency of Canada (PHAC) Research Forum. Fort Gary Hotel, Winnipeg, MB. March 20 – 21, 2006.

Christianson, S., M. R. Mulvey. Comparative Genomic Hybridizations of Hospital and Community-Associated MRSA in Canada. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, December 16 – 19, 2005.

Chun EHJ, Kirkpatrick R, Liu J, Palmquist D, Wynhoven B, Ali J, Shenmen C, Wagner L, Howe K, Searle S, Siddiqui A, Holt R, Marra M, Jones S. 2006 Genomics Forum: Student Biotechnology Network Research Exchange. Vancouver, BC. April 2006. An Effective Strategy of Full-Length Clone Selection in Bos taurus

Corbett, C., Gubbins, M., Yuan, X., Schmidt, S., Tsang, R., and J.D. Berry. 2006. Neutralizing MAbs targeting Domain 2 of Bacillus anthracis Protective Antigen ASM Biodefense Research, Feb.15-18, Washington, DC.

Croyle Maria, Heinz Feldmann, Steven Jones, James M. Wilson and Gary P. Kobinger. Nasal delivery of Adenovirus expressing the Ebola glycoprotein protects mice against Ebola virus in the presence of preexisting immunity to the vaccine carrier. Nine Annual International Conference, American Society for Gene Therapy, Baltimore, June 2006.

Cutts, T., Osiowy, C., and He, R. (2006) HCV F Protein as a Potential Diagnostic Marker: Analysis of Reactivity with INNO-LIA HCV Ab III Indeterminate Clinical Serum Samples. [Presented at the 2006 Annual AMMI Canada/CACMID Conference, March 16-19, 2006, Victoria, BC].

Czub M, Berhane Y, Caswell JL, Loosmore S, Audonnet JC, Roth JA, Weingartl HM (2006) Recombinant vaccines protect pigs against challenge with Nipah virus. ASV meeting, Madison, WI, July 15 – 19.

Dao V, Rubinger M, Bow EJ, Schacter BA, Shore TB, Woloschuk D, Demers A, Sun X, Seftel MD. Epidemiology of Adult Acute Lymphoblastic Leukemia in Manitoba, Canada: Does This Approximate Clinical Trial Data? Blood 2005: 106(11) Abstract #4554, p 217b.

DeCorby M, Weshnoweski B, Vashisht R, Karlowsky K, Gonzalez J, Adam H, Nichol K, Zhanel GG, Hoban DJ. Evaluation of antibiotic susceptibility in 26,882 respiratory tract pathogens collected across Canada from 1997-2005: Results of the Canadian Respiratory Organism Susceptibility Study (CROSS). 106th General Meeting of the American Society for Microbiology, Orlando, FL, May 2006.

DeCorby M, Weshnoweski B, Vashisht R, Karlowsky K, Schurek K, Adam H, Hoban DJ, Zhanel GG. Activity of PGE-9262932, an investigational non-fluorinated quinolone (NFQ), against respiratory tract isolates of Streptococcus pneumoniae (SPN) from Canada. 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, December 2005.

DeCorby MR, Weshnoweski B, Vashisht R, Edel M, Karlowsky K, Gonzalez J, Zhanel GG, Hoban DJ. Incidence of penicillin, doxycycline, macrolide and fluoroquinolone resistance in Streptococcus pneumoniae (SPN) in Canada: Results of the Canadian Respiratory Organism Susceptibility Study (CROSS), 1997-2004. 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, December 2005.

Decorby, M., N. Laing, B. Weshnoweski, M. Edel, K. Karlowsky, J. A. Karlowsky, R. Vashisht, C. Siemens, M. McCracken, M. R. Mulvey, D. J. Hoban and G. G. Zhanel. Antimicrobial Resistance in Pathogens Isolated from Canadian Intensive Care Units: Results of the Canadian National Intensive Care Unit (CAN-ICU) Study 2005. Association of Medical Microbiology and Infectious Diseases (AMMI)/Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID), Victoria, BC. March 15 – 19, 2006.

DeGagne P, Alfa MJ, Helewa M, Avery L, Harding GK. The Rapid Group B Streptococcus PCR Test Provides a Method for Reliable Detection of GBS Carriage in Women in Labour. Presented at the 2006 Canadian Society of Medical Laboratory Sciences and Manitoba Society of Medical Laboratory Technology (CSMLS/MSMLT) Joint Congress of Medical Laboratory Science. Winnipeg, Manitoba. May 28-31, 2006.

Delaney AD, Li HI, Nayar T, Baross A, Ally A, Asano J, Bailey D, Birch P, Brown-John M, Cao M, Chan S, Eydoux P, Fernandes N, Flibotte S, Go A, Holt RA, Jones S, Kennedy G, Krzywinski M, Langlois S, Schein J, Siddiqui A, Friedman JM, Marra MA. The Biology of Genomes. Cold Spring Harbor Laboratory, NY. May 2006. Gene copy number variants, the limits of detection using Affymetrix SMP genotype chips.

Dore, K., W. Demczuk, L.-K. Ng, R. Ahmed, L. Dutil and M. R. Mulvey. Antimicrobial Resistance among Human Salmonella Isolated in Canada: Two Years of National Surveillance. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, December 16 – 19, 2005.

Douville R, Li Y, Bastien N, Becker A , Kozyrskyj A and HayGlass KT. Asthmatic Children Display Increased Th1 Biased Immunity to Human Metapneumovirus. 62nd American Adamedy of Allergy Asthma and Immunology, Maimi Beach, Florida, USA (March 3-7, 2006).

Drebot MA, Lindsay R, Andonova M, Artsob H, Guzman M, Pupo M. Serological Evidence for West Nile Virus Infection of Humans and Horses in Cuba. 2006 National Conference on West Nile Virus in the United States. San Franciso, California., February 23-24, 2006.

Drebot Michael, Anna Andonova, Anton Andonov and Runtao He. “Inhibition of Arbovirus Replications by Aurintricarboxilic acid” Oct. 2006, Ottawa. Annual Conference of Canadian Federation of Biological Society.

Dutil, L., L.-K. Ng, M. R. Mulvey, R. Ahmed, W. Demczuk, R. Finley, K. Doré, F. Jamieson, B. Ciebin, J. Joly, J. Ismail, J. Isaac-Renton, A. Paccagnella, L. MacDougall, B. Radke, D. Leger, B. Avery, D. Daignault, A. Muckle, R. Irwin and the CIPARS Collaborative. Increase in ampC Resistance among Salmonella Heidelberg from Human and Poultry Sources in Canada. 2006 International Conference on Emerging Infectious Diseases (ICEID) in the United States. Atlanta Marriott Marquis. March 19 – 22, 2006.

Dyck, M., Elliott, L., Simonsen, N. Exploring the Risk Factors of West Nile Virus Disease. Guelph, ON: Canadian Society of Epidemiology and Biostatistics Student Research Conference, June 2006.

Dyck, M., Elliott, L., Simonsen, N. Risk Factors of West Nile Virus Disease. Winnipeg, MB: 1st Annual PHAC Research Forum, March 2006.

Dyck, M., Elliott, L., Simonsen, N. The Risk Factors of West Nile Virus Disease. Winnipeg, MB: Canadian Health Sciences Student Research Conference, June 2006.

Ebihara Hideki, Xiangguo Qiu, Steven Theriault, Matthew Klassen, Ute Stroeher, Jim Strong, Steven Jones, James M. Wilson, Heinz Feldmann and Gary P. Kobinger. Comparative analysis of different methods for quantitative evaluation of neutralizing antibody to Ebola virus in a biosafety level 2 or 4 environment. Nine Annual International Conference, American Society for Gene Therapy, Baltimore, June 2006.

Embil JM, Graham D, Soto NE, Melnick DA. Complicated Skin and Skin Structure Infections (cSSSI) in Diabetic Patients: Bacteriology and Clinical Efficacy of Meropenem (MEN) and Imipenem-Cilastatin (IMP). Inner Science Conference on Antimicrobial Agents and Chemotherapy. December 18, 2005. Abstract L-1570.

Friedman JM, Arbour L, Armstrong L, Bailey D, Baross A, Birch P, Brown-John M, Cao M, Chan S, Charest DL, Delaney A, Eydoux P, Farnoud N, Fernandes N, Flibotte S, Gibson W, Go A, Hanson R, Holt

R, Jones S, Kennedy G, Krzywinski M, Langlois S, Li I, McGillivray B, Rajcan-Separovic E, Schein J, Siddiqui A, Van Allen M, Yong S-L, Marra M. 55th Annual Meeting of The American Society of Human Genetics. Salt Lake City, UT. October 2005. High-resolution analysis of genomic imbalance in children with mental retardation.

Gilbert, M., J. Conly, J. MacDonald, J. Siushansian, D. Gregson, S. Elsayed, K. Zhang, K. Laupland, M. Louie, M. R. Mulvey, T. Louie, D. Nielsen, V. Wheeler, T. Lye, G. Keyes and J. Gillespie. Possible Role of Sexual Activity in Propagation of an Outbreak of CMRSA10 Community - Acquired Methicillin Resistant Staphylococcus aureus (CAMRSA) in a Marginalized Urban Population (MUP). Association of Medical Microbiology and Infectious Diseases (AMMI)/Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID), Victoria, BC. March 15 – 19, 2006.

Gilmour MW, Tracz DM, Tabor H, Jerome M and Ng L-K. Identification of Genetic Determinants and Polymorphisms Specific for Human-Adapted Serovars of Salmonella enterica causing Enteric Fever. International Conference on Emerging Infectious Diseases (ICEID). March 19-22, Atlanta, Georgia, USA. Abstract published on page 178 of the conference program, 2006.

Gin AS, Weshnoweski B, Laing N, Hoban DJ and Zhanel GG. Antibiotic use and antibiotic resistant S. pneumoniae in Canada from 1998-2004. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington DC, 2005.

Gin AS, Weshnoweski B, Laing N, Hoban DJ, Zhanel GG. Antibiotic Resistant S. pneumoniae and Antibiotic Use in Canada from 1998-2004. Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington D.C. December 2005. Abstract K-2089.

Gin AS, Weshnoweski B, Laing N, Hoban DJ, Zhanel GG. Changes in Antibiotic Prescribing Among Physician Specialties in Canada from 1996-2004. Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington D.C. December 2005. Abstract K-2098.

Glogowska A, Klonisch T. ProEGF cytoplasmic domain (proEGFcyt): A novel factor in EGFR-mediated signalling and growth. Manitoba Health Research Poster Competition (CSHRF); University of Manitoba, Winnipeg, Canada.

Glogowska A, Weber E, Hoang-Vu C, Klonisch T. Human proEGF Cytoplasmic domain affects cathepsin expression in FTC-133 thyroid carcinoma cells. 3rd Northern Light Summer Conference and 9th Annual Canadian Light Source Users’ Meeting, Saskatoon, Canada.

Gozho, G.N., J.C. Plaizier, and D.O. Krause, 2006. Effects of grain induced subacute ruminal acidosis on rumen lipopolysaccaride and inflammation in Holstein cows. J. Dairy Sci. 89:(Suppl. 1):404-405.

Gravel, D., Paton, S., Perkins, P., Henry, B., McGeer, A., Vearncombe, M., Christian, M., Barry, C., Simor, A., Ofner, M., Mederski, B., Koch, J., Nicolle, L.E. Acute care facility experiences in providing care for SARS patients in Toronto. Abstract P2-15, AMMI-Canada/CACMID 2005, Annual Conference. Can Jour Infect Dis 2005; 16:134.

Green, C. and J. L. Wylie. An ecological population-based study of Campylobacter incidence: Searching for etiological clues. 2005. Annual International Centre for Infectious Disease symposium, Winnipeg, MB.

Greenberg DP, Doemland ML, Lavigne P, Galanis E, Kamdola K, Bettinger JA, Halperin SA, Scheifele DW, IMPACT investigators (J Embree, site coordinator). Impact of Pentacel (DtaP-IPV/PRP-T) on the epidemiology of invasine Hib Disease and pertussis in Canada. 5th Pediatric Infectious Disease Society Conference, Napa, California October 10-11, 2005. Abst #10.

Griffith OL, Jones SJM. BC Cancer Agency Annual Cancer Conference 2005. Vancouver, BC. November 2005. Differential coexpression analysis for the identification of dysregulated genes in prostate cancer.

Griffith OL, Jones SJM. University of British Colmubia Medical Genetics Research Retreat. Vancouver BC. November 2005. Differential Co-Expression Analysis for the Identification of Dysregulated Genes in Prostate Cancer.

Griffith OL, Montgomery SB, Bilenky M, Pleasance ED, Prychyna Y, Sleumer MC, Zhang X, Jones SJM. PSB 2006. Maui, HI. January 2006. ORegAnno: An open access database and curation system for literature-derived, experimentally-verified promoters, transcription factor binding sites, and regulatory variation.

Griffith OL, Wiseman SM, Jones SJM. 97th Annual Meeting for the American Association for Cancer Research. Washington, DC. April 2006. Meta-analysis of thyroid cancers expression profiling studies – Identification of most promising biomarkers for tissue microarray analysis.

Griffith OL, Wiseman SM, Jones SJM. BC Cancer Agency Annual Cancer Conference 2005. Vancouver, BC. November 2005. Meta-analysis of thyroid cancers expression profiling studies – Identification of most promising biomarkers for tissue microarray analysis.

Hahné S, J Macey, Y van der Veen, R van Binnendijk, G Tipples, S Dolman, H Ruijs, A Timen, AW van Loon, H de Melker. Rubella outbreak in the Netherlands: new rubella genotype spread to Canada and led to congenital rubella infections. International Conference on Emerging Infectious Diseases, Atlanta, USA, March 19-22, 2006.

Halaschek-Wiener J, Oliveira L, Madden K, Jones S, Connors J, Lee ND, Meneilly G, Marra Ma, Brooks-Wilson A. BC Cancer Agency Annual Cancer Conference 2005. Vancouver, BC. November 2005. Genetics of healthy aging: a population-based study.

Harris R, Booth SA, “Microarray Analysis of Mouse Follicular Dendritic Cells from the Spleen During Prion Infection”, 1st Annual Public Health Agency of Canada (PHAC) Research Forum, Winnipeg (2006).

Harris R., E. Gibb & S. Booth, “Microarray Analysis of Mouse Follicular Dendritic Cells from the Spleen During Prion Infection”, International Centre for Infectious Diseases Research and innovation Retreat, Winnipeg, (2005).

Hay, K, Corbett, C, Plummer, FA, and JD Berry 2006. Mucosal Antibody Variable Gene Usage in HIV-1 Exposed Seronegative Individuals. 1st Annual Public Health Agency of Canada (PHAC) Research Forum, Mar. 20-21, Winnipeg.

Hay, K., Corbett, C., Plummer, F., and J.D. Berry. 2006. A novel mammalian cell expression – screening system for human immunoglobulin; Applications of Mucosal antibody libraries to ESN and Human Immunodeficiency Virus 1, Univ. Nairobi HIV/AIDS Collaborative group meeting, January 23-27.

He, R., C. Pankiw, C. Rypien, T. Cutts, M. LaFreniere, M. Carpenter and T. Booth. Oncogene up-regulation induced by NS3 protein. 12th International meeting on hepatitis C virus and related viruses, Montreal, PQ, Oct 2-6, 2005. Poster P-302.

Heaman, M., Newburn-Cook, C., Green, C., Elliott, L., & Helewa, M. Comparison of prenatal care utilization measures in predicting risk of preterm birth. Journal of Obstetrics and Gynaecology Canada, 2005; 27(5):S18. Presented at: Society for Pediatric and Perinatal Epidemiologic Research 18th Annual Meeting, Toronto, July 2005.

Hirst M, Delaney A, Rogers SA, Schnerch A, Persaud DR, O’Connor M, Zeng T, Moksa M, Fitcher K, Mah D, Ma K, Lee S, Menzies S, Khattra J, Morin R, Siddiqui A, Holt R, Jones S, Thomson JA, Eaves CJ, Marra MA. 2006 Genomics Forum: Student Biotechnology Network Research Exchange. Vancouver, BC. April 2006. Characterizing the expressed genome of human embryonic stem cells through deep longsage profiling coupled with high-throughput race rescue of novel transcripts.

Hisanaga T, Nelson K, Tohme S, Tam J, Wierzbowski A, Hoban DJ and Zhanel GG. Single step mutants of Streptococcus pneumoniae with varying macrolide resistance phenotypes and the minimum macrolide inhibition (MMI) and minimum ketolide inhibition (MKI) concentration. America Society for Microbiology (ASM), New Orleans, Louisiana, 2005.

Hisanaga TL, Rusen J, Hoban DJ and Zhanel GG. Stability of Macrolide and ketolide resistance in Streptococcus pneumoniae clinical isolates and laboratory-derived single step mutants. American Society for Microbiology (ASM), Orlando, Florida, May 2006.

Hoban D, Bouchillon S, Johnson B, Stevens T, Johnson J, Dowzicky M. Tigecycline in vitro activity in currnet European pathogens – T.E.S.T. Program 2006. 16th European Congress of Clinical Microbiology and Infectious Diseases (ECCMD), Nice, France, April 2006.

Hoban D, Johnson B, Bouchillon S, Stevens T, Johnson J, Dowzicky M. Multi drug resistant (MDR) S. aureus are susceptible to Tigecycline: T.E.S.T. program-United States surveillance. 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, December 2005.

Hoban D, Johnson B, Bouchillon S, Stevens T, Johnson J, Dowzicky M. In vitro activity of tigecycline and comparators against community and hospital acquired infections in the United States – T.E.S.T. Program 2006. 16th European Congress of Clinical Microbiology and Infectious Diseases (ECCMD), Nice, France, April 2006.

Hoban D, Johnson B, Bouchillon S, Stevens T, Johnson J, Dowzicky M. In vitro activity of tigecycline and 10 broad spectrum comparators against multi drug resistant Staphylococcus aureus: A multi-nation evaluation. 16th European Congress of Clinical Microbiology and Infectious Diseases (ECCMD), Nice, France, April 2006.

Hoban D, Johnson B, Bouchillon S, Stevens T, Johnson J, Dowzicky M. Multi-drug resistant S. aureus are susceptible to tigecycline: T.E.S.T. Program – United States surveillance. 16th European Congress of Clinical Microbiology and Infectious Diseases (ECCMD), Nice, France, April 2006.

Hoban D, Johnson B, Bouchillon S, Stevens T, Johnson J, Dowzicky M. Multi-drug resistant Staphylococcus aureus in vitro activity to tigecycline and 10 comparators – European T.E.S.T. Program 2006. 16th European Congress of Clinical Microbiology and Infectious Diseases (ECCMD), Nice, France, April 2006.

Hoban D, Johnson B, Bouchillon S, Stevens T, Johnson J, Dowzicky M. Tigecycline in vitro activity against multi-drug resistant Acinetobacter spp. In the T.E.S. T. Program global data. 16th European Congress of Clinical Microbiology and Infectious Diseases (ECCMD), Nice, France, April 2006.

Hoban D, Johnson B, Bouchillon S, Stevens T, Johnson J, Dowzicky M. Evaluating cross resistance for Enterobacteriaceae as compared to tigecycline for the T.E.S.T. Program in Europe. 16th European Congress of Clinical Microbiology and Infectious Diseases (ECCMD), Nice, France, April 2006.

Hoban DJ, Adam HJ, Schurek KN, Vashisht R, Weshnoweski B, Nichol K, Zhanel GG. Are fluoroquinole (FQ) resistant S. pneumoniae (SPN) increasing in Canada? Results of an 8 year (1998-2005) national multi-site study. 106th General Meeting of the American Society for Microbiology, Orlando, FL, May 2006.

Hoban DJ, Karlowsky K, Karlowsky JA and Zhanel GG. Macrolide resistant Streptococcus pyogenes in Canada: Results of the multi-year CROSS study. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington DC, 2005.

Hoban DJ, Noreddin A, Hisanaga T, DeCorby M, Laing N, Wierzbowski A and Zhanel GG. Telithromycin and azithromycin pharmacodynamics vs. genotypically characterized (mefA and ermB) macrolide resistant strains of Streptococcus pneumoniae simulating free serum and free epithelial lining fluid concentrations. European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Copenhagen, 2005.

Hoban DJ, Palatnick LP, Weshnoweski B, Wierzbowski A, Nichol K and Zhanel GG. Activity of telithromycin and oral comparators against 20,886 Canadian respiratory tract pathogens isolated from 1997-2003. European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Copenhagen, 2005.

Hoban DJ, Weshnoweski B, DeCorby M, Hoban C and Zhanel GG. Tigecycline is highly active against 2084 bacteremic Streptococcus pneumoniae (SPN) in Canada (2002-2004). Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington DC, 2005.

Hoban DJ, Weshnoweski B, Vashisht R, Zhanel GG. Macrolide resistant Streptococcus pyogenes in Canada: Results of the multi-year CROSS study (1999-2004). 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, December 2005.

Hoban DJ, Weshnoweski B, Wierzbowski AK, Nichol K, Zhanel GG. Telithromycin vs. respiratory tract infection (RTI) pathogens in Canada 1997-2005: Resistance is not an issue. 106th General Meeting of the American Society for Microbiology, Orlando, FL, May 2006.

Hoban DJ, Weshnoweski B, Zhanel GG, Vashisht R, Edel M, Karlowsky K, Mulligan B. Antifungal susceptibility of Aspergillus and Penicillium species in Canadian neutropenic patients: Results of a 5 year national survey 2000-2004. 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, December 2005.

Holloway KA, Mubareka S, Safronetz D, Burbidge E, Artsob H, Drebot M. Development of real time and conventional RT-PCR assays for the identification of snowshoe hare and Jamestown Canyon viruses. Association of Medical Microbiology and Infectious Disease Canada – Canadian Association for Clinical Microbiology and Infectious Diseases Annual Conference, Ottawa, Ontario. April 14-17, 2005.

Hoodless PA, Vrljicak1 P, Hou J, Cullum R, McKnight KD, Montpetit R, Rupert JL, Wu MK, Charters A, Siddiqui A, Helgason CD, Simpson EM, Jones S, Marra M. 3rd Canadian Developmental Biology Conference. Mont-Tremblant, QU. April 2006. The Mouse Atlas of Gene Expression.

Howie R, Alfa M. Modelling Microbial Survival in Build-Up Biofilm for Complex Medical Devices. Presented at AMMI Canada – CACMID 2006 Annual Meeting. Victoria, British Columbia. March 15 – 19, 2006.

Iacovides H, Ariano R, Harding G, Zelenitsky S. Empiric Therapy Using Combinations Prevents the Emergence of Antibiotic-Resistant Enterobacter cloacae in an in vitro Infection Model. Presented at the 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC. December 16 - 19, 2005.

Isabel, S., E. Leblanc, M. Boissinot, D. K. Boudreau, M. Grondin, F. Picard, N. Parham, P. H. Roy, M. Ouellette, D. E. Bader, M. R. Mulvey, M. G. Bergeron. Phylogeny of Yersinia Species Based on a Unique Variability among Genes Encoding the Elongation Factor Tu. 106th American Society for Microbiology General Meeting, Orlando, FL, 2006.

Johnson B, Bouchillon S, Steven T, Johnson J, Hoban D, Dowzicky M. Cross-resistance in clinical isolates of Enterobacteriaceae from the United States evaluated against tigecycline and 10 comparator antimicrobial agents. 16th European Congress of Clinical Microbiology and Infectious Diseases (ECCMD), Nice, France, April 2006.

Johnson B, Bouchillon S, Stevens T, Johnson J, Hoban D, Dowzicky M. Tigecycline antibacterial activity in current (2004-05) U.S. pathogen population. 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, December 2005.

Johnson B, Bouchillon S, Stevens T, Johnson J, Hoban D, Dowzicky M. As in vitro evaluation of Tigecycline in an in-patient vs. out-patient population worldwide. 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, December 2005.

Johnson B, Bouchillon S, Stevens T, Johnson J, Hoban D, Dowzicky M. The T.E.S.T. program-determining the anti-bacterial activity of tigecycline and 10 comparators in a global population. 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, December 2005.

Johnson B, Bouchillon S, Stevens T, Johnson J, Hoban D, Dowzicky M. Vancomycin-resistant enterococci (VRE): a global problem: evalution of Tigecycline against recent isolates from multi-centers globally. 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, December 2005.

Johnson B, Bouchillon S, Stevens T, Johnson J, Hoban D, Dowzicky M. In vitro activity of Tigecycline against multi-drug resistant Acinetobacter from the T.E.S.T. program worldwide. 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, December 2005.

Johnson B, Bouchillon S, Stevens T, Johnson J, Hoban D, Dowzicky M. Determining Tigecylcine’s in vitro activity multi-drug resistant Enterobacteriaceae globally. 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, December 2005.

Johnson B, Bouchillon S, Stevens T, Johnson J, Hoban D, Dowzicky M. In vitro activity of Tigecycline against multi-drug resistant Acinetobacter in the United States – T.E.S.T. Program 2004-2005. ASHP Midyear Clinical Meeting, Las Vegas, NV, December 2005.

Johnson B, Bouchillon S, Stevens T, Johnson J, Hoban D, Dowzicky M. Evaluating antibiotic coss-resistance in clinical isolates of Enterobacteriaceae from the United States against 10 antimicrobial agents – The T.E.S.T. Program. ASHP Midyear Clinical Meeting, Las Vegas, NV, December 2005.

Johnson B, Bouchillon S, Stevens T, Johnson J, Hoban D, Dowzicky M. Determining Tigecycline in vitro activity against multi-drug resistant Enterobacteriaceae for the T.E.S.T. Program. ASHP Midyear Clinical Meeting, Las Vegas, NV, December 2005.

Johnson B, Bouchillon S, Stevens T, Johnson J, Hoban D, Dowzicky M. Tigecycline in vitro activity in an out-patient vs. in-patient global population. 16th European Congress of Clinical Microbiology and Infectious Diseases (ECCMD), Nice, France, April 2006.

Johnson B, Bouchillon S, Stevens T, Johnson J, Hoban D, Dowzicky M. Tigecycline antibacterial activity in current (2004-06) U.S. pathogen population. 16th European Congress of Clinical Microbiology and Infectious Diseases (ECCMD), Nice, France, April 2006.

Johnson B, Bouchillon S, Stevens T, Johnson J, Hoban D, Dowzicky M. Multi-drug resistant Acinetobacter in the United States evaluated against tigecycline – T.E.S.T. Program 2006. 16th European Congress of Clinical Microbiology and Infectious Diseases (ECCMD), Nice, France, April 2006.

Johnson B, Bouchillon S, Stevens T, Johnson J, Hoban D, Dowzicky M. Determining tigecycline’s in vitro activity multi-drug resistant Enterobacteriaceae from the T.E.S.T. Program – Global Data. 16th European Congress of Clinical Microbiology and Infectious Diseases (ECCMD), Nice, France, April 2006.

Johnson B, Bouchillon S, Stevens T, Johnson J, Hoban D, Dowzicky M. Resistnat Enterobacteriaceae in United States data from the T.E.S.T. Program – Tigecycline in vitro activity with 10 comparators. 16th European Congress of Clinical Microbiology and Infectious Diseases (ECCMD), Nice, France, April 2006.

Johnson B, Bouchillon S, Stevens T, Johnson J, Hoban D, Dowzicky M. Determining multi-drug resistant isolates for Enterobacteriaceae as compared to tigecycline for the T.E.S.T. Program in Europe. 16th European Congress of Clinical Microbiology and Infectious Diseases (ECCMD), Nice, France, April 2006.

Johnson B, Bouchillon S, Stevens T, Johnson J, Hoban D, Dowzicky M. In vitro evaluation of tigecycline against 261 recent isolates of vancomycin resistant enterococci (VRE) – T.E.S.T. Program 2006. 16th European Congress of Clinical Microbiology and Infectious Diseases (ECCMD), Nice, France, April 2006.

Johnson B, Bouchillon S, Stevens T, Johnson J, Hoban D, Dowzicky M. Evaluating tigecycline against cross resistant Enterobacteriaceae in the global T.E.S.T. Program. 16th European Congress of Clinical Microbiology and Infectious Diseases (ECCMD), Nice, France, April 2006.

Johnson B, Bouchillon S, Stevens T, Johnson J, Hoban D, Dowzicky M. Tigecycline in vitro activity against multi-drug resistant Acinetobacter from global population in the T.E.S.T. Program 2006. 16th European Congress of Clinical Microbiology and Infectious Diseases (ECCMD), Nice, France, April 2006.

Johnson B, Hoban D, Bouchillon S, Stevens T, Johnson J, Dowzicky M. T.E.S.T.: Validating the activity of Tigecycline (TIG) in current European pathogens. 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, December 2005.

Johnson B, Johnson J, Hoban D, Bouchillon S, Stevens S, Dowzicky M. Tigecycline in vitro activity against Staphylococcus aureus and Enterococcus spp. Resistant to other antimicrobials. 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, December 2005.

Johnson B, Jordan A, Bouchillon S, Hoban D, Scangarella N, Shawar R, Johnson J. In vitro activity of Retapamulin (sb-275833), a novel topical antimicrobial against 3,486 gram-positive isolates associated with skin and skin structure infections (SSSIs) from 14 sites in North America. 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, December 2005.

Johnson J, Hoban D, Johnson B, Bouchillon S, Stevens T, Dowzicky M. In-patient vs. out-patient in vitro evaluation of pathogens collected from centers in Europe. 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, December 2005.

Johnson J, Hoban D, Johnson B, Bouchillon S, Stevens T, Dowzicky M. Tigecycline in vitro activity against Staphylococcus aureus and Enterococcus strains resistant to other drugs in the T.E.S.T. program-United States, 2004-2005. 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, December 2005.

Johnson J, Hoban D, Johnson B, Bouchillon S, Stevens T, Dowzicky M. Tigecycline in vitro activity against Staphylococcus aureus and Enterococcus strains resistant to other drugs in the T.E.S.T. Program – United States, 2004-2005. ASHP Midyear Clinical Meeting, Las Vegas, NV, December 2005.

Johnson J, Hoban D, Johnson B, Bouchillon S, Stevens T, Dowzicky M. Acinetobacter resistance in the United States: In vitro evaluation of Tigecycline and comparators against recent isolates. ASHP Midyear Clinical Meeting, Las Vegas, NV, December 2005.

Johnson J, Hoban D, Johnson B, Bouchillon S, Stevens T, Dowzicky M. Tigecycline in vitro activity against in-patient and out-patient pathogens collected from centers in Europe – T.E.S.T. Program 2006. 16th European Congress of Clinical Microbiology and Infectious Diseases (ECCMD), Nice, France, April 2006.

Johnson J, Hoban D, Johnson B, Bouchillon S, Stevens T, Dowzicky M. Tigecycline in vitro activity against often difficult to treat pathogens from centers in Asia/Pacific Rim – T.E.S.T. Program 2006. 16th European Congress of Clinical Microbiology and Infectious Diseases (ECCMD), Nice, France, April 2006.

Johnson J, Hoban D, Johnson B, Bouchillon S, Stevens T, Dowzicky M. In vitro activity of multi-drug resistant Acinetobacter against tigecycline from the T.E.S.T. Program in Europe. 16th European Congress of Clinical Microbiology and Infectious Diseases (ECCMD), Nice, France, April 2006.

Johnson J, Hoban D, Johnson B, Bouchillon S, Stevens T, Dowzicky M. Acinetobacter resistance in clinical isolates from the United States evaluated against tigecycline and 10 comparators. 16th European Congress of Clinical Microbiology and Infectious Diseases (ECCMD), Nice, France, April 2006.

Johnson J, Hoban D, Johnson B, Bouchillon S, Stevens T, Dowzicky M. Sampling of Staphylococcus aureus and Enterococcus species isolates resistant to other drugs evaluated against tigecycline – T.E.S.T. Program global data. 16th European Congress of Clinical Microbiology and Infectious Diseases (ECCMD), Nice, France, April 2006.

Johnson J, Hoban D, Johnson B, Bouchillon S, Stevens T, Dowzicky M. Tigecycline in vitro activity against Staphylococus aureus and Enterococcus strains resistant to other drugs in United Stataes, 2004-2006. 16th European Congress of Clinical Microbiology and Infectious Diseases (ECCMD), Nice, France, April 2006.

Johnson J, Johnson B, Hoban D, Bouchillon S, Stevens T, Dowzicky M. Evaluation of Tigecycline against often difficult to treat pathogens from centers in Asia/Pacific Rim. 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, December 2005.

Kabani A, Aramini JJ, Mukhi S, Kuschak T, Kettner J, Blangez B. Edge V, McDonald L, Mukhi S, Hoffman E, Honke D, Parker S. June 2005. Presentation. Canadian Network for Public Health Intelligence. Proceedings of the 2005 CRTI Summer Symposium, 20-22 June 2005, Gatineau Quebec, pp63-64. http://www.crti.drdc-rddc.gc.ca/en/publications/symposium_proceedings/CRTI_symposium_ proceedings_2005_e.pdf.

Kabani, A., ; Corbett, C., et al., 2006. CRTI 03-0021TD: Assay Development and Production Team for Developing, Validating, Producing, and Distributing Assays for the Identification of Bioterrorism



Agents: Development of New Antibodies and Reagents to botulinum neurotoxins, CRTI Summer Symposium 2006, June 3-6, Gatineau Quebec.

Kabani, A., Gubbins M., et al., 2006. CRTI 03-0021TD: Assay Development and Production Team for Developing, Validating, Producing, and Distributing Assays for the Identification of Bioterrorism Agents: Development of New Antibodies and Reagents to F. tularensis and Y. pestis, CRTI Summer Symposium 2006, June 3-6, Gatineau Quebec

Karlowsky JA, Nichol KA, Wierzbowski AK, Hoban DJ, Zhanel GG. Prevalence of inducible clindamycin resistance among Streptococcus pyogenes isolated in 24 Canadian medical centres from 2002 to 2005. 106th General Meeting of the American Society for Microbiology, Orlando, FL, May 2006.

Keelan, M., C. Gebhart, G. Sandhu, L. Price, L.-K. Ng, and D.E. Taylor. 2005. Combining results of flaA-RFLP, PFGE and seotyping identifies 5 dominant groups of human Campylobacter jejuni isolates associated with retail poultry in Alberta, Canada. 13th International Workshop on Campylobacter, Helicobacter, and Related Organisms (CHRO). Gold Coast, Queensland, Australia, September 4-8, 2005.

Kein D., J. Wolfe, M. K. Sharma. Correlation of Genotypic and Phenotypic Antimicrobial Susceptibility Testing for Mycobacterium tuberculosis. The 1st Annual Public Health Agency of Canada (PHAC) Research Forum, March 20-21, 2006, Fort Garry Hotel, Winnipeg, Manitoba.

Keynan Y, Koesters S, Card C, Li Y, Kimani J, Plummer FA and Fowke KR. Measuring the Immune response to Influenza vaccine using multiparametric flow-cytometry based technologies. Public Health Agency of Canada (PHAC) Research Forum, Winnipeg, Manitoba, March 20-21, 2006.

Keynan Y, Koesters S, Card C, Li Y, Kimani J, Plummer FA and Fowke KR. Intranasal cold-adapted, attenuated trivalent influenza vaccine challenge in HIV resistant commercial sex workers. 15th Annual Canadian Conference on HIV/AIDS Research (CAHR). May 25-28, 2006. Quebec City, Quebec.

Khafipoor, E, D.O. Krause and J.C. Plaizier, 2006. Effects of time of feed delivery and subacute ruminal acidosis (SARA) on diurnal variation of free rumen lipopolysaccharide endotoxin (LPS) and acute phase proteins in lactating dairy cows. Proc. Joint Colloquium, Canadian Societies of Agronomy, Animal Science and Horticultural Science, Halifax, NS, August 1-4, 2006:98.

Khafipoor, E, D.O. Krause and J.C. Plaizier, 2006. Influence of grain induced sub-acute ruminal acidosis (SARA on lipopolysaccharide endotoxin (LPS) and acute phase proteins. Proc. Joint Colloquium, Canadian Societies of Agronomy, Animal Science and Horticultural Science, Halifax, NS, August 1-4, 2006:28.

Khafipoor, E., D.O. Krause, and J.C. Plaizier, 2006. Effects of time of feed delivery and grain induced sub-acute ruminal acidosis on diurnal patterns of rumen fermentation and milk production in dairy cows. Proc. 27th Western Nutrition Conference, Winnipeg, MB, September 19-20, 2006:248.

Khafipoor, E., D.O. Krause, and J.C. Plaizier, 2006. Inflammatory response as a diagnostic tool for grain induced sub-acute ruminal acidosis (SARA) in lactating dairy cows. Proc. 27th Western Nutrition Conference, Winnipeg, MB, September 19-20, 2006:249.

Kirkpatrick R, Liao N, Reid K, Peng F, Lucker J, Martin D, Lund S, Siddiqui A, Jones S. Genome Informatics. Cold Spring Harbour Laboratory, NY. November 2005. Genomics Studies in the Grapevine.

Kirkpatrick R, Liu J, Chun E, Palmquist D, Wynhoven B, Ali J, Shenmen C, Wagner L, Howe K, Birney E, Siddiqui A, Holt R, Marra M, Jones S. Plant and Animal Genome XIV Conference. San Diego, CA. January 2006. An efficient strategy for full length clone selection in Bos Taurus.

Knox JD, Boreham DR, Czub S, Wyatt H, Parchaliuk D, Ramdoo B, Mitchel RE. Prion Disease Incubation Period Prolonged by Radiation, Prion 2005, Düseldorf, Germany. October 2005.

Koesters SA, Alimonti JB, Wachichi C, Matu L, Anzala AO, Kimani J, Embree JE, Plummer FA and Fowke KR. IL-7R expression on CD4+ T lymphocytes decreases with HIV disease progression and inversely correlates with immune activation. AIDS Vaccine Conference 2005 Montreal Sept 6-9, 2005. Abstract #831P.

Koesters SA, Alimonti JB, Wachihi C, Matu L, Anzala O, Kimani J, Embree JE, Plummer FA and Fowke KR. IL-7R expression on CD4+ T lymphocytes decreases with HIV disease progression and inversely correlates with immune activation. Public Health Agency of Canada (PHAC) Research Forum, Winnipeg, Manitoba, March 20-21, 2006, Poster # 57.

Koesters SA, Alimonti JB, Wachihi C, Matu L, Anzala O, Kimani J, Embree JE, Plummer FA and Fowke KR. Decreased IL-7Ra expression on CD4+ T lymphocytes in HIV disease inversely correlates with immune activation. Keystone Symposia on HIV pathogenesis and Vaccines, Keystone Resort, Keystone, Colorado, March 27-April 2, 2006, Poster # 241.

Kotloski, R., Sepeheri, S., Bernstein, C. N., and Krause, D. O. (2005) Phylogenetic analysis of Escherichi coli strains isolated from IBD patients. Worlds Congress of Gastroenterology, Montreal, September 11th to 15th.

Kralt D, Embil J, Light B, Cheang M, Crampton T, Wiebe L, Limerick B, Sarsfield P, Macdonald K. Clinical Characteristics and Outcomes of Patients with Pulmonary Blastomycosis. Association of Medical Microbiology and Infectious Diseases Canada/Canadian Association for Clinical Microbiology and Infectious Diseases Annual General Meeting, Victoria, British Columbia, March 16, 2006 (Abstract F-3).

Krzywinski M, Ali J, Barber S, Brown-John M, Chand S, Chiu R, D’Souza B, Featherstone R, Field M, Johnson L, Langlois N, Marcadier J, Mayo M, O’Connor K, Piche R, Del Rio L, Roger J, Tsai M, Wong D, Wong K, Zeng T, Hirst M, Lee D, Mathewson C, Yang G, Wye N, Bosdet I, Birol I, Siddiqui A, Schein J, Holt R, Jones S, Horsman D, Gascoyne R, Connors J, Marra M. 2006 Genomics Forum: Student Biotechnology Network Research Exchange. Vancouver, BC. April 2006. A Sequence-ready physical map of a Follicular Lymphoma genome.

Krzywinski M, Brown-John M, Chand S, Chiu R, D’Souza B, Featherstone R, Field M, Johnson L, Langlois N, Marcadier J, Mayo M, O’Connor K, Piche R, Del Rio L, Roger J, Tsai M, Wong D, Lee D, Mathewson C, Wye N, Bosdet I, Birol I, Siddiqui A, Schein J, Jones S, Horsman D, Gascoyne R, Connors J, M Marra. BC Cancer Agency Annual Cancer Conference 2005. Vancouver, BC. November 2005. A Sequence-ready physical map of a Follicular Lymphoma genome.

Kung S, Michael P, Tonnos M, Brabant D, Ramana CV, Parrillo JE, Kumar Anand and Kumar Aseem. The role that bacterial RNA plays in mediating myocyte contraction depression. Northern Research Conference, Northern Ontario School of Medicine and Algoma University, Sault St. Marie, Ontario, Canada. June 2006.

Labine M, Z-j Ao, G-y Huang, Z-k Xu, X-J Yao. Defining the critical motif(s) within HIV-1 integrase responsible for binding host cellular factor importin 7 and its impact on HIV-1 replication. Manitoba Health Research Poster Competition, U. of Manitoba June 05, 2006.

Labine M,, Z-j Ao G-Y Huang, Z-K Xu, X-J Yao. Requirement of the C-terminal domain of HIV-1 IN for its rapid degradation by cellular machinery. International Centre for Infectious Diseases Research and Innovation Retreat. Fort Garry Hotel, Winnipeg, Oct 28-29, 2005.

Lagacé-Wiens PRS, Nichol KA, Nicolle LE, DeCorby MR, McCracken M, Mulvey MR, Zhanel GG. Treatment of lower urinary tract infection caused by multi-drug resistant extended spectrum beta-lactamase-producing Escherichia coli with amoxicillin/clavulanate. Abstract SP. 09 AMMI-Canada-CACMID 2006 Annual Conference. Can Jour Infect Dis Med Micro 2006; 17:54.

Lagace-Wiens PRS, Nichol KA, Nicolle LE, McCracken M, DeCorby M, Mulvey M and Zhanel GG. Characterization of multidrug resistant ESBL producing E.coli from Manitoba. Association of Medical Microbiology and Infectious Diseases of Canada (AMMI), Victoria, British Columbia, 2006.

Lagacé-Wiens, P. R. S., K. A. Nichol, M. McCracken, M. Alfa, M. Decorby, L. E. Nicolle, M. R. Mulvey and G. G. Zhanel. Characterization of Fluoroquinolone Resistant Extended Spectrum b-Lactamase producing Esherichia coli. Association of Medical Microbiology and Infectious Diseases (AMMI)/Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID), Victoria, BC. March 15 – 19, 2006.

Lemos XRMR, MM Siqueira, GRS Sá, M Gray, GA Tipples. Evaluation of rubella IgG avidity maturation over time in pregnant women. Brazilian Meeting of Virology, Brazil, November, 2005.

Lenton P, Sitter D, Alfa MJ, Harding GK. Evaluation of the 3D BacT/Alert® Automated Instrument for Detection of Mycobacterial Cultures Requiring 30oC Incubation. Presented at the 2006 Canadian Society of Medical Laboratory Sciences and Manitoba Society of Medical Laboratory Technology (CSMLS/MSMLT) Joint Congress of Medical Laboratory Science. Winnipeg, Manitoba. May 28-31, 2006.

Leung S, Griffith O, Phang T, Jones S, Masoudi H, Wiseman S. 2006 Annual Meeting for the American Society of Colon and Rectal Surgeons. Seattle WA. June 2006. Additional variables other than AJCC staging show clinical utility for colon cancer patient prognostication.

Li Y, Bastien N, Li L, Ward D, and Taylaor T. Molecular characterization of the G glycoprotein gene of human metapneumovirus. XIII International Congress of Virology, San Francisco, CA, USA (July 23-28, 2005).

Li YY, An J, Jones SJM. 2006 Genomics Forum: Student Biotechnology Network Research Exchange. Vancouver, BC. April 2006. Finding new protein interactions for old drugs: inverse docking for the prediction of drug side effects.

Liao N, Kirkpatrick R, Liu J, Chun E, Wynhoven B, Palmquist D, Siddiqui A, Jones S. 2006 Genomics Forum: Student Biotechnology Network Research Exchange. Vancouver, BC. April 2006. A Novel Protocol for Filtering, Clustering and Analysizing EST Sequences.

Liu L, Bastien N, Sidaway F, Levett P, and Li Y. Detection of antibodies to human metapneumovirus by a recombinant nucleocapsid protein-based immunosorbent assay. The 1st Annual Public Health Agency of Canada (PHAC) Research Forum. Winnipeg, MB, Canada (March 20-21, 2006).

Lodge A, Orr P, Larcombe L, Martin B. Tuberculosis in a Remove Canadian First Nations Community: The Impact of Virulence, Genetic and Environmental Factors on Epidemiology and Control. (Abstract 199). The 13th International Congress on Circumpolar Health, Novosibirsk, Russia, June 15, 2006.

Macey J, S Dolman, GA Tipples. Outbreak of Rubella in southwestern Ontario in 2005; Challenges for Rubella Elimination in Canada. Public Health Agency of Canada Research Forum. Winnipeg, Canada, March 20-21, 2006.

Majcher M., K. Bernard, S. Sattar. Efficacy of different classes of liquid sporicidal agents against Bacillus anthracis and other Bacillus spp. surrogates, determined by timed interval exposure using QCT-2 protocols. 106th Annual General Meeting American Society for Microbiology. Orlando, Fl. May 23, 2006 poster Y-007.

Majer,A., E.Grudeski, S.Booth, and T.Booth. Gene Expression Profiling of Individual Murine Brain Cells to Investigate Mechanisms of HSV-1 Pathogenesis for Human Encephalitis. University of Manitoba Research Days, June 6 - 8, 2006.

Manda K.D., Y. Fan, X. Yang. Modulation of immune responses to chlamydial infection upon progesterone administration. Keystone symposia: Innate Immunity, Abstract book, p75. Banff, Alberta 2006.

Martinuk,A., S.Booth, E.Grudeski, and T.F.Booth. Host response to HSV-1 infection: gene expression profiling to investigate mechanism of pathogenesis and disease markers. The 30th International Herpesvirus Workshop, 30 July - 5 August 2005 in Turku, Finland. 2005.

Masaro C, Skowronski DM, Mak A, Sebastian R, Petric M, Li Y, David S, McNabb G, De Serres G, and Tam T. Effectiveness of Vaccine Against Medical Consultation Due to Laboratory-Confirmed Influenza: Results From a Sentinel Physician Pilot Project in British Columbia, 2005-2006. The 1st

Annual Public Health Agency of Canada (PHAC) Research Forum. Winnipeg, MB, Canada (March 20-21, 2006).

Mattson CL, Bailey RC, Moses S, Agot K, Ndinya-Achola JO. Sexual practices and risk practices for sexually transmitted infections (STIs) among men in Kisumu, Kenya. Second Annual North American Congress of Epidemiology, Seattle, USA, June 21-24 2006.

McArthur M, McGeer A, Boras V, Church D, Embil J, Lobe M, Louit M, Raboud J, Sarabia A, Shen S, Simor A, Kapela J, Taylor G, Watt C, Louie M. Where Did this MRSA Come From? CHICA – Canada Conference, London, Ontario May 8, 2006.

McCracken, M. G., M. R. Mulvey, K. A. Nichol, M. Decorby, P. R. S. Lagacé-Wiens, G. G. Zhanel. Characterization of North American Quinolone-Resistant Escherichia coli Isolates Harbouring Extended-Spectrum Beta-Lactamases. 106th American Society for Microbiology General Meeting, Orlando, FL. 2006.

McCracken, M., D. Kuntz, G. Soule, W. Demczuk, K. Dore, R. Irwin, L.-K. Ng, R. Ahmed and M. R. Mulvey. Characterization of Extended-Spectrum Beta-Lactamase (ESBL) Genes from Canadian Isolates of Salmonella. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Washington, DC, December 16 – 19, 2005.

McDonald L, Aramini JJ, Mukhi S, Edge V, Kabani A, Parker S. Sept 2005. The Winnipeg Regional Health Authority early detection project: A system overview. Presentation. 2005 Syndromic Surveillance Conference. Seattle, Washington.

McDonald, R. R., P. N. Levett, R. Kitzul, K. L. Montgomery, T. Du, D. A. Boyd, N. A. Antonishyn, G. B. Horsman and M. R. Mulvey. The Identification of Clostridium difficile Containing Binary Toxin in Saskatchewan. Association of Medical Microbiology and Infectious Diseases (AMMI)/Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID), Victoria, BC. March 15 – 19, 2006.

McIntyre L, L. De Winter, K. Bernard, B. Auk, J. Fung, J. Isaac-Renton, D. Beniac, B. Ng, D. Wiebe, T. Burdz. Identification of Bacillus thuringiensis among Bacillus cereus group isolates associated with British Columbia food poisoning events. 74th CACMID co-meeting with AMMI Victoria, BC. March 17 2006 (poster P2.17, abstract cited in Can. J Inf. Dis. Med Microbiol. 17:67).

McKenzie,E.J., J.Sun, M.Jackson, T.Booth, Y.Deschambault, E.Grudeski, M.L.H.Gruwel, and J.Cao. Using 31P-MRS and serum analysis to monitor the response to HSP70-WHcAg vaccinations in the woodchuck model of chronic viral hepatitis. University of Manitoba Research Days, June 6 - 8, 2006.

McKinnon LR, Ball TB, Stuart T, Wachihi C, Kamene J, Anzala O, Maingi A, Chinga N, Luo M, Fowke KR, Plummer FA. Variant HIV epitopes: immunological relevance for HIV-specific CD8+ T cell proliferative responses? Keystone HIV Vaccines X6. March 26-April 2, 2006 Keystone, CO.

McKinnon LR, Ball TB, Wachihi C, Fowke KR, Plummer FA. Epitope mapping HIV-specific CD8+ T cell responses in a Kenyan cohort. 15th Annual Canadian Conference on HIV/AIDS Research (CAHR). May 25-28, 2006. Quebec City, Quebec.

McLaren PJ, Mayne M, Matu L, Kimani J, Plummer FA, Fowke KR. Microarray analysis reveals high levels of CD4+ T cell dysfunction in asymptomatic HIV infected individuals. First Annual Public Health Agency of Canada Research Forum. 2006 March 13-14, Winnipeg, Manitoba. Abstract #64.

Miller M, Gravel D, Mulvey M, McGeer A, Simor A, Taylor G, Hutchinson J, Gardam M, Boyd D, Valiquette L, Kelly S, Ouellet C, Canadian Nosocomial Infection Surveillance Program (J Embil and J Embree, members). Surveillance for nosocomial Clostridium difficle associated diarrhea (N-CDAD) within acute-care hospitals in Canada: Results of the 2005 Nosocomial Infections Surveillance program (CNISP) Study shows escalating mortality. SHEA 2006, Chicago, USA March 18-21, 2006. Abst # 151.

Miller M, Gravel D, Mulvey M, McGeer A, Simor A, Taylor G, Hutchinson J, Gardam M, Boyd D, Valiquette L, Kelly S, Ouellet C, Canadian Nosocomial Infection Surveillance Program (J Embil and J Embree, members) . Presence of a highly virulent clone of clostridium difficle (CD) among Canadian hospitals: strain characterization and correlation with severe disease and death. SHEA 2006, Chicago, USA March 18-21, 2006. Abstr # 152.

Montgomery SB, Bainbridge M, Griffith OL, Schinas J, Brooks-Wilson A, Jones SJM. 2006 Genomics Forum: Student Biotechnology Network Research Exchange. Vancouver, BC. April 2006. In Silico approach to the Identification of Regulatory Polymorphisms within Promoter Regions of Homo Sapiens using Comparative Genomics, Regulatory Feature and Sequence Composition Metrics.

Montgomery SB, Griffith O, Schinas J, Brooks-Wilson A, Jones SJM. BC Cancer Agency Annual Cancer Conference 2005. Vancouver, BC. November 2005. In Silico Determination of Functional Non-Coding Polymorphisms.

Moore SS, Luo Guan L, Lobo S, Meng Y, Taniguchi M, Wang Z, Stott J, Ali J, Kirkpatrick R, Siddiqui A, Barber S, Babakaiff R, Beland J, Chand S, Chun HJE, Del Rio L, Dreolini L, Featherstone R, Gibson S, Liu J, Matsuo C, Mayo M, Palmquist D, Roger J, Tsai M, Wong D, Wynhoven B, Yang G, Schreiber K, Prange C, Shapiro N, Shenmen C, Wagner L, Alexander L, MacNeil M, Brownstein MJ, Holt R, Jones S, Marra M. Plant and Animal Genome XIV Conference. San Diego, CA. January 2006. Bovine Genome Sequencing Program: Full-length cDNA Sequencing.

Morin RD, Chang E, Petrescu A, Liao N, Baross A, Hirst M, Kirkpatrick R, Griffith M, Butterfield YS, Stott J, Barber S, Babakaiff R, Matsuo C, Wong D, Yang GS, Smailus DE, Brown-John M, Mayo M, Beland J, Gibson S, Olson T, Tsai M, Featherstone R, Chand S, Siddiqui AS, Marra MA, Jones SJM, Holt RA. BC Cancer Agency Annual Cancer Conference 2005. Vancouver, BC. November 2005. The Mammalian Gene Collection: A growing resource of clones of human, mouse, rat, xenopus and zebrafish, is rich in genes implicated in oncogenesis.

Morin RD, Chang E, Petrescu A, Liao N, Griffith M, Kirkpatrick R, Butterfield YS, Young AC, Stott J, Barber S, Babakaiff R, Dickson MC, Matsuo C, Wong D, Yang GS, Smailus DE, Wetherby KD, Kwong PN, Grimwood J, Brinkley III CP, Brown-John M, Reddix-Dugue N, Mayo M, Schmutz J, Beland J, Park M, Gibson S, Olson T, Bouffard GG, Tsai M, Featherstone R, Chand S, Siddiqui AS, Jang M, Lee E, Klein SL, Blakesley RW, Zeeberg BR, Sudarshan N, Weinstein JN, Pennacchio CP, Myers RM, Green ER, Wagner L, Gerhard DS, Marra MA, Jones SJM, Holt RA. Genomics Forum and Research Exchange 2006. Vancouver, BC. Apr 2006. Sequencing and analysis of 10,967 full-length cDNA clones from Xenopus laevis and Xenopus tropicalis.

Moses S, Bailey RC, Agot K, Parker CB, Maclean IW, Ndinya-Achola JO. A randomized controlled trial of male circumcision to reduce HIV incidence in Kisumu, Kenya: progress to date [Abstract TO-702]. XV Biennial Congress of the International Society for STD Research (ISSTDR), Amsterdam, The Netherlands, July 10-13, 2005.

Moses S, Reza Paul S, Washington RG, Ramesh BM, Alary M, Blanchard JF. Presumptive treatment for cervical infection among female sex workers in Mysore, India [Abstract TP-173]. XV Biennial Congress of the International Society for STD Research (ISSTDR), Amsterdam, The Netherlands, July 10-13, 2005.

Mubareka, S., Loeb, M., Simor, A., Liu, B., McNeil, S., Mazowita, G., Duckworth, H., Cheang, M., Nicolle, L. Use of diagnostic tests in lower respiratory infection in long-term care facilities in Winnipeg, Manitoba. Abstract P1-33 AMMI-Canada/CACMID 2005 Annual Conference. Can Jour Infect Dis 2005; 16:129.

Murray MR, Alfa MJ, Sitter D, Guenther J, Pang P. Cholestyramine for Oral Suspension USP can Mask Clostridium difficile toxins in Stool when Assayed by Triage® C.difficile Panel and Cytotoxin Assay. Presented at AMMI Canada – CACMID 2006 Annual Meeting. Victoria, British Columbia. March 15 – 19, 2006.

Nahra R, Mankad A, Zanotti S, Kumar A. Mycobacterium Tuberculosis: An unusual yet highly fatal cause of septic shock. Chest 2005;128:380S

Nichol KA, Hoban DJ, Zhanel GG. Comparison of the molecular epidemiology of penicillin-, clarithromycin-, and ciprofloxacin-resistant Streptococcus pneumoniae in Canada from 1998-2005. 106th General Meeting of the American Society for Microbiology, Orlando, FL, May 2006.

Nichol KA, Laing NM, Embree J, Hoban DJ, Zhanel GG. Serotype distribution of penicillin-resistant Streptococcus pneumoniae isolated in Canada from 1997-2004: Baseline analysis pre-introduction of Prevnar. 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, December 2005.

Nichol KA, Mayer M, DeCorby MR, Arishi H, Rusen J, Siemens CG, Laing NM, Johnson J, The NAUTICA-QR Group, Hoban DJ, Zhanel GG. Molecular epidemiology of fluoroquinolone-resistant outpatient urinary isolates of Escherichia coli in North America. 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, December 2005.

Noreddin A, Reese AM, Hoban DJ and Zhanel GG. Pharmacodynamic target attainment analysis of garenoxacin compared to gemifloxacin, moxifloxacin, gatifloxacin and levofloxacin versus S. pneumoniae in serum and epithelial lining fluid of patients with community acquired pneumonia (CAP). International Society of Chemotherapy-Community Acquired Pneumonia (ISC-CAP) Conference, Montreal, 2005.

Noreddin A.M., A.M. Reese, D.J. Hoban and G.G. Zhanel. Pharmacodynamic profiling of Telithromycin 800mg Once Daily, Azithromycin 500/250mg Once Daily and Clarithromycin 500mg Twice Daily in Plasma and Epithelial Lining Fluid versus S. pneumoniae: Monte Carlo simulation study of patients with Community Acquired Pneumonia. International Society of Chemotherapy-Community Acquired Pneumonia (ISC-CAP) meeting, September 15, 2005, .Montreal, Canada.

Noreddin AM, Hoban DJ and Zhanel GG. Monte carlo simulation of bactericidal activity versus P.aeruginosa of levofloxacin 500mg, 750mg and 1000mg once daily compared to gatifloxacin 400mg once daily administered to critically ill patients”. American College of Clinical Pharmacy, Annual Meeting, San Francisco, October 23-26, 2005.

Noreddin AM, Hoban DJ and Zhanel GG. Pharmacodynamic modeling of telithromycin and azithromycin vs. genotypically characterized (mefA and ermB) macrolide resistant strains of Streptococcus pneumoniae simulating free serum and free epithelial lining fluid concentrations”. American College of Clinical Pharmacy, Annual Meeting, San Francisco, US. San Francisco, October 23-26, 2005.

Offner M, Simor A, McGer A, Hodnett E, Gravel D, Loeb M, Mulvey M, Bryce E, Canadian Hospital Epidemiology Committee, Canadian Nosocomial Infection Surveillance Program (J Embil and J Embree, members). Outcomes and predictors of in-hospital mortality associated with invasive methicillin-resistant Stapgylococcus aureus (WRSA) infection . SHEA 2006, Chicago, USA March 18-21, 2006. Abstr # 161.

Ofner M, Mulvey M, Simor A, McGeer A, Gravel D, Hirji Z, McCraken M, Boyd D, Canadian Nosocomial Infection Surveillance Program (J Embil and J Embree, members) , Bryce E. Outcomes, predictors and laboratory analysis of patients harbouring extended spectrum beta lactamase (ESBL) or AmpC resistant organisms in Canadian hospitals. SHEA 2006, Chicago, USA March 18-21, 2006. Abst # 255..

Olson N, Buelow-Smith L, Alfa MJ. Testing Cleaning Efficacy of a New Bedpan Washer. Presented at Joint CSMLS/MSMLT Congress 2006. Winnipeg, Manitoba. May 28 – 31, 2006.

Olson, A.B., A.K. Andrysiak, L. Chui, L.-K. Ng, and M.W. Gilmour. 2006. Molecular serotyping of Shiga toxin-producing Escherichia coli using genetic targets encoded outside of the O-antigen gene cluster. PHAC Research Forum, Public Health Agency of Canada, March 20-21, 2006. Winnipeg, Manitoba.

Osiowy, C., Heathcote, J., Zoulim, F., Willems, B., and Villeneuve, J. (2005) Resistance to Adefovir Dipivoxil in Patients with Lamivudine-Resistant Chronic Hepatitis B. [Presented at the 2005 American Association for the Study of Liver Diseases Meeting, San Francisco, CA].

Osiowy, C., Rahmanian, R., Borlang, J., Petric, M., and Krajden, M. (2006) Prevalence of Occult Hepatitis B Virus in a Cohort of High-Risk HIV- and HCV-Infected Individuals in British Columbia. [Presented at the 2006 Annual AMMI Canada/CACMID Conference, March 16-19, 2006, Victoria, BC].

Osiowy, C., Villeneuve, J., Heathcote, J., Giles, E., and Borlang, J. (2006) Detection of Mutations Associated with Resistance to Adefovir Dipivoxil in Chronic Hepatitis B Virus Patients by the INNO-LiPA HBV DR v2 Assay. [Presented at the 2006 Annual AMMI Canada/CACMID Conference, March 16-19, 2006, Victoria, BC].

Oyugi J., J. Alimonti, F. Vouriot, A. Land, S. Wayne, Z-J Ao, X-J, Yao, F.A. Plummer, J. Berry, and K.R. Fowke. The role of CD4 polymorphism on HIV-1 infection and disease progression. Manitoba Health Research. Poster Competition, U. of Manitoba June 05, 2006.

Pakhale S, Roberts D, Light R, Sharma S, Kumar A. A geographically and temporally comprehensive analysis of septic shock: Impact of age, sex and socioeconomic status. The Toronto Critical Care Medicine Symposium 2005.

Palmquist D, Huang P, Wynhoven B, Chun E, Kirkpatrick R, Ali J, Sidiqqui A, Holt R, Marra M, Jones S. 2006 AGBT Meeting. Marco Island, FL. February 2006. Ensuring Transparent and Consistent High Quality in cDNA Finishing.

Pang P, Wald A, Alfa MJ, Harding GK. Comparison of Triage® to TechLab® Tests for Detection of Clostridium difficile Associated Diarrhea (CDAD) in Stool Samples. Presented at the 2006 Canadian Society of Medical Laboratory Sciences and Manitoba Society of Medical Laboratory Technology (CSMLS/MSMLT) Joint Congress of Medical Laboratory Science. Winnipeg, Manitoba. May 28-31, 2006.

Patterson, R., Connor, M. L., Nyachoti, C. M., and Krause, D. O. (2006) Effects of conjugated linoleic acid (CLA) on sow and litter performance. ADSA-ASAS 2006 Joint Annual Meeting, July 9-13th 2006, Minneapolis, USA.

Pelude, L., J. L. Wylie, and A. M. Jolly. Are drug using networks formed by Injection Drug Users truly random? 2005. Canadian Association of HIV researchers, Vancouver, BC.

Pelude, L., G. Wells, L. Leonard, J. Wylie, and A. Jolly. How important is network structure in the transmission of disease among injection drug users? 2005. Ontario HIV Treatment Network, Toronto, ON.

Peters GA, SD Tyler, C Grose, A Severini, MJ Gray, R Garceau, V Tcherepanov, C Upton, GA Tipples. Complete genomic analysis of 18 varicella-zoster virus isolates provides insight into attenuation, recombination and genotyping strategies. Public Health Agency of Canada Research Forum. Winnipeg, Canada, March 20-21, 2006.

Peters GA, SD Tyler, M Gray, C Grose, GA Tipples. Complete DNA sequence analysis of 11 varicella-zoster virus isolates provides insight into mechanisms of attenuation. 30th International Herpesvirus Workshop, Turku, Finland, July 30th to August 5, 2005.

Plaizier J.C. and D.O. Krause, 2006. Rumen acidosis in dairy cattle. Proc. 27th Western Nutrition Conference, Winnipeg, MB, September 19-20, 2006: 111-123.

Plaizier, J.C., G.N. Gozho, and D.O. Krause, 2006. Rumen microbial community analysis and lipopolysaccharide concentrations in cattle with subacute ruminal acidosis. Proc 11’th Int. Symp. Mircob. Ecol. Vienna Austria August 20-25, 2006:A70.

Plaizier, J.C., S. Wamnes, E. Khafipoor, A. Nikkhah, and D.O. Krause, 2006. Effects of grain induced subacute ruminal acidosis (SARA) on feeding behaviour of dairy cows. Proc. Joint Colloquium, Canadian Societies of Agronomy, Animal Science and Horticultural Science, Halifax, NS, August 1-4, 2006:61.

Pleasance ED, Sleumer MC, Bilenky M, Chuang M, Dagpinar M, Griffith OL, He A, Lin K, Montgomery S, Oveisi M, Pan W, Robertson G, Robertson N, Teague K, Varhol R, Yuen W, Zhang M, Gorski SM, Siddiqui A, Jones SJM. BC Cancer Agency Annual Cancer Conference 2005. Vancouver, BC. November 2005. A method for genome-wide CIS-Regulatory element discovery I Drosophila Melanogaster.

Qiu H., Y. Fan, A.G. Joyee, S. Wang, X. Yang. Type I interferons promote susceptibility to Chlamydia trachomatis lung infection. Keystone symposia: Innate Immunity, Abstract book, p85. Banff, Alberta 2006.

Quayle AP, Siddiqui AS, Jones SJM. BC Cancer Agency Annual Cancer Conference 2005. Vancouver, BC. November 2005. Application of Interaction Networks for the Prediction of Drug Discovery combinations in cancer therapy.

Quayle AP, Siddiqui AS, Jones SJM. ISCB 2005 – Sixth Internationl Conference on Systems Biology. Boston, MA. October 2005. Application of Interaction Networks for the Prediction of Drug Discovery combinations in cancer therapy.

Raouf A, Zhao Y, To K, Stingl J, Delaney A, Schnerch A, Asano J, Jones S, Emerman J, Marra M, Eaves C.Canadian Breast Cancer Research Alliance meeting. Montreal QU. May 2006. Characterization of primitive human mammary epithelial cells.

Rau, N. V., G. Gindi, T. Du, D. Spreitzer, M. R. Mulvey and A. Pyoderma. Cluster Caused by a New Community-Acquired MRSA (CA-MRSA) Strain in a Family of Egyptian Origin. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, December 16 – 19, 2005.

Reese A., G.G. Zhanel, D.J. Hoban and A.M. Noreddin. Pharmacodynamic Target Attainment Analysis of Garenoxacin Compared to Gemifloxacin, Moxifloxacin, Gatifloxacin and Levofloxacin versus S. pneumoniae in Serum and Epithelial Lining Fluid of Patients with Community Acquired Pneumonia”. International Society of Chemotherapy-Community Acquired Pneumonia (ISC-CAP) meeting, September 15, 2005, .Montreal, Canada.

Reid K, Liao N, Kirkpatrick R, Stott J, Peng F, Schlosser J, Shukin R, Bowen P, Holt R, Jones S, Marra M, Bohlmann J, Lund S. Plant Biology 2005. Seattle, WA. July 2005. Development of an EST Database for Gene Discovery in Wine Grape.

Reza Paul S, Moses S, Ramesh BM, Halli S, Washington R, Modal S, Blanchard JF. An integrated behavioral and biological study among female sex workers in Mysore, India [Abstract MP-106]. XV Biennial Congress of the International Society for STD Research (ISSTDR), Amsterdam, The Netherlands, July 10-13, 2005.

Roberecki SA, Simonsen N, Weiss E, Lim G, Drebot M, Shymanski M, West Nile Study Group. West Nile Virus Serosurvey: Southwestern Manitoba. 2006 National Conference on West Nile Virus in the United States. San Franciso, California., February 23-24, 2006.

Robertson C, Booth SA, Beniac DR, Coulthart MB, Booth TF McNicol A, “Cellular prion protein is on the platelet alpha granule membrane and is released on exosomes following activation”, 1st Annual Public Health Agency of Canada (PHAC) Research Forum, Winnipeg (2006).

Romanuik T, Holt R, Jones S, Marra M., Sadar MD. BC Cancer Agency Annual Cancer Conference 2005. Vancouver, BC. November 2005. Discovery of Genes involved in cross-talk between the androgen and PKA pathways in prostate cancer using long serial analysis of gene expression.

Ruzanov P, Jones SJ, Moerman DG, Riddle DL. 2006 Genomics Forum: Student Biotechnology Network Research Exchange. Vancouver, BC. April 2006. Discovery of novel alternatively spliced transcripts based on computational predictions supported by SAGE data in C.elegans.

Rypien C. and M.S.Carpenter. Protein binding partners of hepatitis C virus (HCV) protein NS3. 12th International Symposium on hepatitis C virus and related viruses, Montreal, PQ, Oct 2-6, 2005. Poster P-307.

Saba R., G. Sorensen, M. B. Coulthart & S. A. Booth, “Differential expression of brain associated miRNAs during prion pathogenesis”, International Centre for Infectious Diseases Research and innovation Retreat, Winnipeg, (2005).

Sarna C, Ball TB, Gubbins M, Berry J, Plummer FA. 2006. Investigation of novel IgA antibody variable heavy and light chains from Kenyan HIV-1 resistant sex workers of the Pumwani cohort. XVI International AIDS Conference Toronto, Aug 13-18.

Schein J, Krzywinski M, Barber S, Brown-John M, Chan S, Chand S, Chiu R, Corbett R, D’Souza B, Featherstone R, Field M, Griffith M, Johnson L, Li I, Langlois N, Marcadier J, Mayo M, O’Connor K, Piche R, Pugh T, Del Rio L, Roger J, Tsai M, Wong D, Wye N, Yang G, Zeng T, Baross A, Flibotte S, Hirst M, Lee D, Mathewson C, Bosdet I, Birol I, Siddiqui A, Jones S, Holt R, Horsman D, Gascoyne R, Connors J, Marra M. The Biology of Genomes. Cold Spring Harbor Laboratory, NY. May 2006. Physical map of a Follicular Lymphoma genome: Identification and sequencing of genomic rearrangements.

Schurek K, et al (Hoban DJ). In vitro activity of Garenoxacin against molecularly characterized ciprofloxacin-resistant Streptococcus pneumoniae. 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, December 2005.

Schurek K, et al (Hoban DJ). In vitro activity of PGE-9262932 against 164 clinical isolates of ciprofloxacin-resistant S. pneumoniae. 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, December 2005.

Schurek KN, Adam HJ, Hoban DJ and Zhanel GG. Fluoroquinolone-susceptible Streptococcus pneumoniae do not exhibit reserpine-inhibited efflux of ciprofloxacin: Comparison of 1997 and 2003 Canadian isolates. America Society for Microbiology (ASM), New Orleans, Louisiana, 2005.

Sepeheri, S., Kotlowski, R., Bernstein, C. N., and Krause, D. O. (2005) Comparison of human intestinal bacterial communities in inflammatory bowel disease patients with automated ribosomal intergenic spacer analysis. Worlds Congress of Gastroenterology, Montreal, September 11th to 15th.

Shanaah A, Zanotti S, Parrillo S, Taiberg L, Feinstein D, Suppes R, Roberts D, Kumar A. Impact of body mass index on mortality in patients with septic shock. Critical Care Medicine 2005;33:A164

Shead S, Sonnenburg K, Sidaway F, Horsman G, Levett P, Dawood M, Artsob H, Drebot M. An evaluation of four test formats to discriminate between recent and past exposure to West Nile virus. Association of Medical Microbiology and Infectious Disease Canada – Canadian Association for Clinical Microbiology and Infectious Diseases Annual Conference. Ottawa, Ontario. April 14-17, 2005.

Siddiqui A, Robertson G, Bilenky M, Astakhova T, Griffith OL, Hassel M, Lin K, Montgomery S, Oveisi M, Pleasance E, Robertson N, Sleumer MC, Teague K, Varhol R, Zhang M, Jones S. 2005 IEEE Computational Systems Bioinformatics Conference. August 2005. Stanford University, CA. Cis-regulatory element prediction in mammalian genomes.

Skowronski DM, Li Y, Tweed SA, Larder A, Tam T, Petric M, David ST, Marra F, Bastien N, King A, Lee SW, Prendergast P, Kraiden M, and Brunham RC. Protective measures and human antibodies response during a large poultry outbreak of avian influenza A H7N3 in British Columbia, Canada. The 1st Annual Public Health Agency of Canada (PHAC) Research Forum. Winnipeg, MB, Canada (March 20-21, 2006).

Skowronski DM, Li Y, Tweed SA, Tam T, Petric M, David ST, Larder A, Birch P, Marra F, Seto J, Bastien N, Lee SW, Prendergast P, Kraiden M, and Brunham RC. Protective measures and human antibodies response during a poultry outbreak of highly pathogenic avian influenza A H7N3 in British Columbia, Canada 2004. The Second European Influenza Conference (ESWI), Malta, p70 (September 11-14, 2005).

Sleumer MC, Bilenky M, Dagpinar M, Griffith OL, He A, Pan W, Pleasance ED, Robertson AG, Yuen W, Zhang X, Jones SJM. 2006 Genomics Forum: Student Biotechnology Network Research Exchange. Vancouver, BC. April 2006. de Novo Detection of Regulatory Modules in C. elegans.

Sleumer MC, Bilenky M, Griffith OL, Pan W, Pleasance ED, Robertson AG, Zhang X, Jones SJM. BC Cancer Agency Annual Cancer Conference 2005. Vancouver, BC. November 2005. The Search for Regulatory Elements in the model organism C. elegans.

Stevens T, Johnson J, Hoban D, Johnson B, Bouchillon S, Dowzicky M. Asia and Pacific Rim community vs. hospital acquired infections – in vitro activity against tigecycline and comparators. 16th European Congress of Clinical Microbiology and Infectious Diseases (ECCMD), Nice, France, April 2006.

Stevens T, Johnson J, Hoban D, Johnson B, Bouchillon S, Dowzicky M. Extended spectrum beta-lactamase producing Enterobacteriaceae evaluated in vitro against tigecycline and comparator agents – T.E.S.T. Program 2006. 16th European Congress of Clinical Microbiology and Infectious Diseases (ECCMD), Nice, France, April 2006.

Stevens T, Johnson J, Hoban D, Johnson B, Bouchillon S, Dowzicky M. Tigecycline in vitro activity against Acinetobacter spp. Resistant to other drugs from Europe – T.E.S.T. Program 2006. 16th European Congress of Clinical Microbiology and Infectious Diseases (ECCMD), Nice, France, April 2006.

Stobart M, Carpenter M, Knox JD. “Use of Hammerhead Ribozymes for Knocking out prnp Gene Expression in a Human Neuroblastoma Cell Line.” International Centre for Infectious Diseases Research and Innovation Retreat, Winnipeg October 2005.

Strong, James E. and Heinz Feldmann. The Ras/MAPK Pathway Enhances Ebola Virus Infectivity: A Potential Mechanism to Break Virus Dormancy in the Natural Reservoir. Filoviruses: Recent Advances and Future Challenges. September 17-19, 2006. An ICID Global Symposium, Winnipeg, Manitoba.

Tam T, Watkin K, Payette P, Graham ML, Mantha S, and Li Y. The H2N2 event: Lessons for influenza surveillance, risk assessment and pandemic preparedness. The 1st Annual Public Health Agency of Canada (PHAC) Research Forum. Winnipeg, MB, Canada (March 20-21, 2006).

Tessier M, Tonnos M, Michael P, Brabant D, Kung S, Ramana CV, Parrillo JE, Kumar Anand and Kumar Aseem. Characterization of signaling pathways that occur during sepsis. Northern Research Conference, Northern Ontario School of Medicine and Algoma University, Sault St. Marie, Ontario, Canada. June 2006.

Thottingal P, Barasa S, Wachihi C, Gakii G, Kusimba J, Kamunya G, Jaoko W, Embree J, Gelmon LJ; Disclosure of HIV Status – An Obstacle to Initiating ARV Medications in a Pediatric Setting in Kenya; presented at the XIVth International Conference on AIDS/STDs in Africa, Abuja, Nigeria, December 2005; Abstract WeOrC107, Abstract volume, pg.41.

Thottingal P, Wachihi C, Njoki J, Bwibo E, Kamene J, Mboya S, Lester R, Plummer F, Ball B Gelmon LJ; Female Commercial Sex Workers and Antiretroviral Delivery in Nairobi, Kenya: Peer-Led

Networks in Prevention of HIV and Antiretrovial Care; presented at the XIVth International Conference on AIDS/STDs in Africa, Abuja, Nigeria, December 2005; Abstract TuPoB00153, Abstract volume, pg.148.

Tracz DM, Andrysiak AK, Clark CG, Tyson S, Severini A, Ng L-K and Gilmour MW. Molecular Typing of Shiga Toxin-Producing Escherichia coli Using the espZ gene Encoded in the Locus of Enterocyte Effacement. Association of Medical Microbiology and Infectious Diseases Canada (AMMI Canada) and Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID). Annual Conference, March 15-19, Victoria, British Columbia, Canada, 2006..

Tran, A.T., W. Xu, M.K. Patrick, T. Racine, D.A. Selaghi, and K.M. Coombs. (2005). Characterization of avian reovirus assembly-defective temperature-sensitive mutants. XIIIth International Congress of Virology, San Francisco, California, July 23-28.

Trojanowicz B, Chen Z, Bialek J, Radestock Y, Hombach-Klonisch, Klonisch T, Finke R, Dralle H, Hoang-Vu C. Influence of AUF1 targeting siRNA on cell cycle-related proteins in thyroid cancer cell lines. 50. Tagung der Deutschen Gesellschaft für Endokrinologie (DGE), Essen, Germany.

Trojanowicz B, Winkler A, Hammje K, Chen Z, Sekulla C, Glanz D, Schmutzler C, Mentrup B, Hombach-Klonisch S, Klonisch T, Finke R, Köhrle J, Dralle H, Hoang-Vu C. Retinoic acid actions are connected with downregulation of ENO1 gene products in the follicular thyroid carcinoma cell line FTC-133. 50. Tagung der Deutschen Gesellschaft für Endokrinologie (DGE), Essen, Germany.

Trojanowicz B, Winkler A, Hammje K, Chen Z, Sekulla C, Glanz D, Schmutzler C, Mentrup B, Hombach-Klonisch S, Klonisch T, Finke R, Köhrle J, Dralle H, Hoang-Vu C. Influence of retinoic acid on post-translational modifications in follicular thyroid carcinoma cell line FTC-133. 50. Tagung der Deutschen Gesellschaft für Endokrinologie (DGE), Essen, Germany.

Trojanowicz B, Winkler A, Hammje K, Chen Z, Sekulla C, Glanz D, Schmutzler C, Mentrup B, Hombach-Klonisch S, Klonisch T, Finke R, Köhrle J, Dralle H, Hoang-Vu C. Effect of RA on proteome of thyroid carcinoma cell line FTC-133. DGPF Bioperspectives 2005, Wiesbaden, Germany.

Tyler SD and Severini A (2006) The complete genomic sequence of Herpes Virus Papio 2 reveals evidence of recombination of possible pathogenesis genes.1st Annual Public Health Agency of Canada (PHAC) Research Forum, March 20-21, Fort Garry Hotel, Winnipeg, Manitoba.

Tyler Shaun, Anton Andonov, Todd Cutts, Jingxin Cao, Xuguangli and Runtao He. “The SR-Rich motif of SARS-CoV nucleocapsid Protein is important of the Replication of the Virus” Oct. 2006. Ottawa. Annual Conference of Canadian Federation of Biological Society.

Vinh DC, Nicole K, Rand F, Embil JM. When is a Bacteremia Not Just a Bacteremia. Association of Medical Microbiology and Infectious Diseases Canada/Canadian Association for Clinical Microbiology and Infectious Diseases Annual General Meeting, Victoria, British Columbia, March 16, 2006 (Abstract CV.03).

Wang G, Jones S, Marra M, Sadar MD. 2006 Genomics Forum: Student Biotechnology Network Research Exchange. Vancouver, BC. April 2006. Genes targeted by both the androgen and PKA signalling pathways that are dependent upon androgen receptor.

Wang G, Jones S, Marra M, Sadar MD. BC Cancer Agency Annual Cancer Conference 2005. Vancouver, BC. November 2005. Identification of Genes Targeted by the Androgen and PKA Signalling Pathways in Prostate Cancer Cells.

Warren RL, Varabei D, Platt D, Huang X, Messina D, Hillier L, Yang S, Wallis J, Chinwalla A, Siddiqui AA, Schein JE, Marra MA, Jones SJM. Genome Informatics. Cold Spring Harbour Laboratory, NY. November 2005. Real-time contiguity improvement of whole-genome shotgun assemblies using physical maps.

Waruk J, Ball TB, Berry J, Cheng K, Plummer FA. 2006. A novel gp120 speficity for IgG1 b12. XVI International AIDS Conference Toronto, Aug 13-18.

Washington G, Rajarethnam T, Ramesh BM, Moses S, Blanchard JF. Discrepancy between self-reported clinical practice and mystery patient assessments in the evaluation of STI syndromic case management by medical practitioners in Karnataka, India [Abstract MP-165]. XV Biennial Congress of the International Society for STD Research (ISSTDR), Amsterdam, The Netherlands, July 10-13, 2005.

Wierzbowski AK, Swedlo D, Nichol K, Hisanaga T, Griesman J, Schurek K, Laing N, Hoban DJ, Zhanel GG. Molecular characterization of macrolide resistant Streptococcus pneumoniae isolates containing both erm(B) and mef(A) genes isolated during 1997-2004 Canadian Respiratory Organism Susceptibility Study (CROSS). 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, December 2005.

Wierzbowski AK, Swedlo D, Nichol K, Hisanaga T, Nikulin A, Strachounski L, Kozlov R, Hoban DJ, Zhanel GG. Macrolide resistant Streptococcus pneumoniae with both mef(A) and erm(B) genes are increasing in Canada: Results obtained from 1997-2004 Canadian Respiratory Organism Susceptibility Study (CROSS). 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, December 2005.

Wolfe J., K. Blackwood-Antonation, M. K. Sharma, A. Kabani, V. J. Cook. A Case of Acquired Rifampin Resistance in Mycobacterium bovis Bacillus Calmette-Guerin Induced Cystitis - Necessity for Treatment Guidelines. 10th Annual Meeting of IUATLD-North American Region, Chigaco, IL.

Wolfe J., M. K. Sharma, K. Blackwood-Antonation, V. J. Cook. A Case Of Acquired Rifampin Resistance In Mycobacterium Bovis Bacillus Calmette-Guerin Induced Cystitis – Necessity For Treatment Guidelines. 2006 AMMI-CACMID meeting, Victoria, Vancouver, Canada, March 15-19, 2006.

Xie Y-Y, Bohacec S, Lee LLC, Delaney A, Khattra J, Holt R, Siddiqui A, Jones SJM, Marra MA, Simpson EM.8th Annual Meeting of IBANGS. Vancouver BC. May 2006. Knowing your behavioural model: LCM-LongSAGE-Lite established for the developing mouse brain.

Xu Z-k, Z-j Ao, G-Y Huang, X-J Yao. Genetic and biological characterization of HIV-1 integrase-induced lethal phenotype in yeast and genetic selection of anti-IN peptides. Manitoba Health Research Poster Competition, U. of Manitoba June 05, 2006.

Yao X-J, Z-J Ao, Q-Y Huang, H Yao, Z-K Xu, M Labine. The functional role of human immunodeficiency virus type 1 integrase during early stage of viral replication. International Symposium on Recent Advances in Molecular, Clinical and Social Medicine sponsored by the Shantou University and University of Manitoba, Shantou, China, Dec 03-05, 2005.

Yoav K, Keynan Y, Koesters SA, Card CM, Li Y, Kimani J, Plummer FA, and Fowke KR. Measuring the Immune response to Influenza vaccine using multiparametric flow-cytometry based technologies. The 1st Annual Public Health Agency of Canada (PHAC) Research Forum. Winnipeg, MB, Canada (March 20-21, 2006).

Yoshida C, Franklin K, McQuiston J, Rahn K, Taboada, Clark C, Fields P, Nash J. Development of an Oligonucleotide Microarray for Determination of Salmonella Serotype. International Conference on Emerging Infectious Diseases, Atlanta, March, 2006.

Yu, Nancy, Hammond, G. A cross-sectional analysis on the Impact of Obesity and Chronic Conditions on Health-Related Quality of Life: A Canadian Population-Bsed Study. Accepted for presentation at The Obesity Society’s 2006 Annual Scientific meeting October 20 – 24, 2006.

Yusuf S, Piedimonte G, Auais A, Demmler G, Krishan S, Van Caeseele P, Singleton R, Broor S, Parveen S, Avendano L, Parra J, Chavez-Bueno S, Simoes E, Welliver R Sr. An analysis of the effects of meteorological conditions on the epidemic activity of respiratory syncytial virus. Presented at American Pediatric Society/Society for Pediatric Research, Washington, DC, 2005: number 500.

Zarychanski R, Gulati H, Roberts D, Sharma S, Houston DS, Kumar A. Systemically administered heparin is associated with increased survival in patients diagnosed with septic shock. The Toronto Critical Care Medicine Symposium 2005. Can J Anesthesia 2006;53:418-419

Zhanel GG, DeCorby MR, Laing NM, Nichol KA, Weshnoweski BJ, Vashisht R, Johnson J, Harding GKM, The NAUTICA-QR Group, Hoban DJ. Antibiotic resistance in fluoroquinolone resistant (FR) outpatient urinary isolates of E. coli in North America: Final results from the North American Urinary Tract Infection Collaborative Alliance – Fluoroquinolone Resistance (NAUTICA-QR). 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, December 2005.

Zhanel GG, Derkatch S, Laing N, Noreddin AM, Hoban DJ. Pharmacodynamic (PD) Activity of Free Ertapenem (Erta) vs. Penicillin-Susceptible (PenS) and Penicillin-Nonsusceptible (PenNS) Streptococcus pneumoniae (SPN) Using an In Vitro Model. The 45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), December 16-19, Washington, DC., 2005.

Zhanel GG, James J, Derkatch S, Laing N, Noreddin AM, Hoban DJ. Pharmacodynamic (PD) Activity of Free Garenoxacin (Gare) vs. Ciprofloxacin-Susceptible and Resistant (ParC, Efflux, ParC with Efflux and ParC/GyrA) Streptococcus pneumoniae (SPN) Using an In Vitro Model. The 45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), December 16-19, Washington, DC., 2005.

Zhanel GG, Laing NM, Weshnoweski BJ, Vashisht R, DeCorby MR, Nichol KA, Johnson J, Harding GKM, The NAUTICA-QR Group, Hoban DJ. Activity of Tigecylcine against fluoroquinolone resistant outpatient urinary isolates of Escherichia coli in North America: Results from the North American Urinary Tract Infection Collaborative Alliance – Quinolone Resistant (NAUTICA-QR). 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, December 2005.

Zhanel, G. G., M. Decorby, N. Laing, B. Weshnoweski, M. Edel, K. Karlowsky, J. A. Karlowsky, R. Vashisht, C. Siemens, M. McCracken, M. R. Mulvey and D. J. Hoban. Activity of the Glycylcycline-Tigecycline against Resistant Pathogens Obtained from Canadian Intensive Care Units: Results of the Canadian National Intensive Care Unit (CAN-ICU) Study 2005. Association of Medical Microbiology and Infectious Diseases (AMMI)/Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID), Victoria, BC. March 15 – 19, 2006.

abstracts presented at meetings july 1, 2001 – june 30, … · web viewadam hj, schurek kn, hoban...

Documents